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SOMMARIO 
  
I polifenoli dietetici possiedono proprietà antiossidanti e antinfiammatorie 
e sono noti per la prevenzione delle malattie degenerative del cancro e delle 
malattie cardiovascolari, ma i loro benefici sulla salute dipendono dalla quantità 
consumata e dalla loro biodisponibilità. Lo scopo di questo studio era di valutare 
l'effetto del trattamento esogeno (orale) del cacao sul danno miocardico acuto 
dopo ischemia coronarica / riperfusione nei ratti a livello istopatologico e 
biochimico. 
 
Estratti metanolici di composti fenolici totali dal quarto di età disponibile 
in commercio di Recioto e polvere di estratto di cacao sono stati analizzati 
utilizzando sia l'HPLC-DAD che l'HPI ESI-MS. 41 diversi composti fenolici sono 
stati rilevati e identificati nel Recioto mentre nel cacao 19 sono stati trovati diversi 
composti fenolici, principalmente derivati dalla catechina e dall'epicatechina. 
Nell'analisi quantitativa (HPLC-DAD) del cacao, sono stati trovati 250 ± 1 mg di 
flavanoli in 1 grammo di estratto di cacao (capsula). Sebbene 90 ± mg di flavanoli 
rilevati in 1 litro di vino rosso Recioto. La quantità di flavonoidi presenti 
nell'estratto di cacao commercialmente è tre volte superiore a quella trovata nel 
vino rosso Recioto. 
 
L'estratto di cacao è stato somministrato per via orale in cinque diversi 
gruppi I, II, III, IV e V di ratti (n = 1) in modo dose-dipendente 5 mg / kg (peso 
corporeo), 10 mg / kg, 15 mg / kg e 25 mg / kg per 15 giorni. Il gruppo VI era 
servito come controllo. Dopo 1 ora di somministrazione orale di cacao, è stato 
raccolto 1 ml di sangue per l'analisi dei polifenoli di cacao nel siero del sangue 
mediante spettrometria di massa HPLC. Questo ha prodotto un corrispondente 
aumento dei polifenoli del siero del sangue ed è diventato costante dopo una dose 
di 15 mg / kg. 
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Un altro esperimento è stato progettato dopo aver ottenuto una dose 
ottimale di polifenoli di cacao nel siero del sangue. In questo esperimento, trenta 
ratti sono stati divisi in gruppi trattati e di controllo. Il gruppo trattato (n = 15) ha 
ricevuto la dose ottimale selezionata (cioè 15 mg / kg) di estratto di cacao ogni 
giorno per 15 giorni oralmente e il gruppo di controllo (n = 15) non è stato 
trattato. Entrambi i gruppi sono stati sottoposti ad occlusione chirurgica 
dell'arteria coronaria discendente anteriore sinistra per 30 minuti e 24 ore di 
riperfusione. Infine, i cuori sono stati asportati e trattati per l'analisi 
biomolecolare. 
 
Lo stato antiossidante nei tessuti del miocardio è stato stimato 
determinando l'attività di perossidasi (POD), catalasi (CAT), superossido 
dismutasi (SOD) e il livello di perossidazione lipidica (TBARS), glutatione 
perossidasi (GSH) è stato misurato mediante spettrofotometro. Sono stati osservati 
effetti marcati migliorati con il trattamento con estratto di cacao (15 mg / kg) ei 
valori di questi biomarcatori sono stati invertiti verso il gruppo di controllo. 
 
L'entità dell'infiammazione di CCL5 / RANATES e IL-6, NF-κB2, 
marcatori di nitro-tirosina e fosforilazione a valle della via signale 
(sopravvivenza) di Erk ½ e Akt è stata osservata mediante immunoistochimica e 
l'apoptosi dei nuclei miocardici è stata analizzata mediante saggio TUNEL. 
Trattamento con estratto di cacao, marcatori infiammatori diminuiti (CCL5 / 
RANTES, IL-6 e NF-KB) e apoptosi miocardica (TUNEL, p <0,01) rispetto al 
gruppo di controllo.  
 
L'attivazione di entrambi p-Akt e p-ERK1 / 2 è stata osservata anche nel 
gruppo trattato con cacao. Il diminuito marcatore infiammatorio e l'apoptosi nel 
cuore di ratto trattato con estratto di cacao potrebbero essere modulati dall'attività 
p-Akt e p-ERK1 / 2. I nostri risultati hanno dimostrato che l'estratto di cacao una 
volta al giorno per 15 giorni nei ratti attenua la lesione I / R miocardica e limita lo 
stress ossidativo e nitrosativo e l'infiammazione con riduzione dell'apoptosi 
miocardica. 
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           La dose ottimale di estratto di cacao che si trova nel modello di ratto può 
avere anche un valore traslazionale nell'uomo. Ad esempio, se il peso corporeo 
medio di 70 kg di esseri umani richiede 3.000 mg di estratto di cacao per 15 giorni 
può avere effetti simili come riduzione dello stress ossidativo, apoptosi e 
marcatori infiammatori che possono essere modulati dalle attività di Akt e 
ERK1/2. 
 
I risultati di questo studio sono riassunti nella figura 1 seguente:  
 
 
Figura: 1. Riepilogo / risultati dello studio: il grafico illustra le quantità di 
flavonoidi nell'estratto di cacao e nel vino rosso recioto; effetti dell'estratto di 
cacao su stress ossidativo, infiammazione, apoptosi e chinasi pro-sopravvivenza. 
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SUMMARY 
 
 
Dietary Polyphenols possess antioxidant and anti-inflammatory properties 
and known for the prevention of degenerative diseases cancer and cardiovascular 
diseases, but their health benefits depend upon the amount consumed and their 
bioavailability.  The aim of this study was to evaluate the effect of exogenous 
(oral) cocoa extract treatment on acute myocardial injury following acute 
coronary ischemia/reperfusion in rats at histopathological and biochemical level.  
 
Methanolic extracts of total phenolic compounds from the commercially 
available four years old Recioto red wine and the cocoa extract powder were 
analyzed by using both HPLC-DAD and HPLC ESI-MS. 41 different phenolic 
compounds were detected and identified in Recioto while in cocoa 19 different 
phenolic compounds, mainly derived from catechin and epicatechin, were found. 
In quantitative analysis (HPLC-DAD) of cocoa, 250 ± 1 mg of flavanols were 
found in 1 gram of cocoa extract (capsule). Although 90± mg of flavanols 
detected in1litre of Recioto red wine, the amount of flavonoids found in 
commercially cocoa extract are three times more than those found in Recioto red 
wine. 
 
The cocoa extract was orally administrated into five different groups I, II, 
III, IV and V of rats (n=1) in dose-dependent manner 5mg/kg (body weight), 
10mg/kg, 15mg/kg and 25mg/kg for 15 days. Group VI was served as control. 
After 1 hour of oral administration of cocoa, 1ml of blood was collected for the 
analysis of cocoa polyphenols in blood serum through HPLC-mass spectrometry. 
This produced a corresponding increase in blood serum polyphenols and became 
constant after 15 mg/kg dose. 
 
Another experiment was designed after obtaining an optimal dose of cocoa 
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polyphenols in blood serum. In this experiment, thirty rats were divided into 
treated and control groups. Treated group (n=15) received the optimal selected 
dose (i.e. 15 mg/kg) of cocoa extract daily for 15 days orally and the control 
group (n=15) was remained untreated. Both groups underwent surgical 
occlusion of the left anterior descending coronary artery for 30 minutes and 24 
hours of reperfusion.  Finally, hearts were excised and processed for 
biomolecular analysis.  
 
Antioxidant status in myocardial tissues was estimated by determining the 
activities of peroxidase (POD), catalase (CAT), superoxide dismutase (SOD), and 
the level of lipid peroxidation (TBARS), glutathione peroxidase (GSH) was 
measured by a spectrophotometer. Marked ameliorated effects were observed with 
cocoa extract (15mg/kg) treatment and the values of these biomarkers were 
reversed towards the control group.  
 
The extent of inflammation of CCL5/RANATES and IL-6, NF-κB2, Nitro-
tyrosine markers and downstream phosphorylation of signally pathway (survival 
pathway) of Erk ½ and Akt was observed by immunohistochemistry and 
myocardial nuclei apoptosis was analyzed by TUNEL assay. Treatment with 
cocoa extract diminished inflammatory markers (CCL5/RANTES, IL-6 and NF-
ΚB2) and myocardial apoptosis (TUNEL, p < 0.01) as compared to control group. 
Activation of both p-Akt and p-ERK1/2 was also observed in the cocoa treated 
group. The diminished inflammatory marker and apoptosis in the cocoa extract 
treated rat heart could be modulated by the activity p-Akt and p-ERK1/2. Our 
results demonstrated that cocoa extract once a day for 15days in rats attenuates 
myocardial I/R injury and limits oxidative and nitrosative stress and inflammation 
with reduction of myocardial apoptosis. 
 
The optimal dose of the cocoa extract that is found in rat model may have 
also a translational value in human. For example, if 70kg average body weight of 
human takes 3,000mg of cocoa extract for 15days may have similar effects such 
as reduction of oxidative stress, apoptosis, and inflammatory markers that may 
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be modulated by activities of Akt and ERK1/2.  
 
 
The findings of this study are summarized in the following figure 2: 
 
Figure: 2. Summary/findings of the study: the chart illustrates amounts of 
flavonoids in the cocoa extract and recioto red wine; effects of cocoa extract on 
oxidative stress, inflammation, apoptosis, and pro-survival kinases. 
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ABSTRACT 
 
Background: Consumption of flavonoid-rich nutraceuticals has been 
associated with a reduction in coronary events. The present study analyzed the 
effects of cocoa extract flavonols on myocardial injury following acute coronary 
ischemia/reperfusion.  
 
 Materials and methods: A commercially available cocoa extract was 
identified by chromatographic mass spectra. Nineteen different phenolic 
compounds were identified and 250 mg of flavan-3-ols (procyanidin) were 
isolated in 1 gram of extract. Oral administration of cocoa extract in incremental 
doses from 5mg/kg up to 25 mg/kg were given to five group of Sprague-Dawley 
rats (5 each group) daily for 15 days and additional 5 rats were used as a control 
group. This produced a corresponding increase in blood serum polyphenols and 
became constant after 15 mg/kg dose. Thirty rats were divided into treated and 
control groups. Treated group (n=15) received the optimal selected dose (i.e. 15 
mg/kg) of cocoa extract daily for 15 days orally and the control group (n=15) was 
remained untreated. Both groups underwent surgical occlusion of the left anterior 
descending coronary artery for 30 minutes and 24 hours of reperfusion.  Finally, 
hearts were excised and processed for biomolecular analysis.  
 
 Results: Cocoa extract reversed (p < 0.001) membrane peroxidation, 
nitrosative stress and superoxide dismutase and catalase activity caused by 
myocardial I/R injury. Treatment with cocoa extract diminished inflammatory 
markers (CCL5/RANTES, IL-6 and NFkB2) and myocardial apoptosis (TUNEL, 
p < 0.01). Cocoa treatment also showed activation of both p-Akt and p-ERK1/2. 
The diminished inflammatory marker and apoptosis in cocoa extract treated rat 
heart could be modulated by the activity p-Akt and p-ERK1/2.  
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 Conclusion: The augmentation of cocoa extract once a day for 15days in 
rats attenuates myocardial I/R injury and limits oxidative and nitrosative stress 
and inflammation with reduction of myocardial apoptosis. 
 
 Keywords: Flavonoids, Cocoa extract, Recioto red wine, Ischemia-
reperfusion injury, oxidative stress, apoptosis, inflammatory markers, downstream 
signaling.  
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CHAPTER ONE 
 
1.1. INTRODUCTION 
 
1.2. Cocoa 
 
Cocoa is dry and non-fat powdered manufacture from seeds of Theobroma 
cacao L. Tree and originally, they were found and widely produced in tropical 
regions of Central and South America (Alamu, 2013). Four West African 
countries, Ivory Coast, Ghana, Nigeria, and Cameron are the main cocoa 
producing countries. Ivory Coast is one of the world‘s number one Cocoa 
exporters (Agarwal, 2013). Chocolates, Cocoa Liquor, cocoa powder, 
confectionary, and ganache are made from Cocoa bean (Grivetti et al., 2009). 
Flowers produce directly on the trunk and older branches of a cocoa tree in the 
form of clusters called ‗cauliflory‘. Fruits ‗cacao pod‘ are formed after pollination 
and 20 to 60 seeds called ‗cocoa beans‘ embedded in a white pulp are present in 
each pod (Agarwal, 2013). 
 
Cocoa beans were considered as food of heaven by the Mayans, as they 
were presumably revealed by god Quetzalcoatl (Agarwal, 2013). They believed 
that cocoa beans are more energetic and make them sturdy. Spaniards noticed that 
they can walk long distances without any fatigue and allowed the Aztecs greater 
stamina due to the cocoa consumption. Some Mexican, Mayan and Olmec tribes 
also have well-known the medical importance of these beans (Agarwal, 2013). 
Products made from cocoa have been enjoyed by humans for centuries (Samman 
et al., 2001). 
 
Cocoa contains a naturally occurring compound that is flavonoids, 
theobromine, and magnesium. Cocoa extract is bioactive compounds found in 
cocoa products. Cocoa products are consumed all over the world for its pleasant 
taste and have very stimulating and pleasurable effects (Samman et al., 2001). It 
has been described in many European historical documents that chocolate was not 
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drunk only for favorable drink or dessert but it was also used to treat various types 
of diseases such as cardiac pain and angina (Keen, 2001).  It has been found that 
Kuna Indians, live on Panamas San Blas Islands consume more than four cups of 
cocoa in a week does not show any age-related blood pressure and heart related 
diseases (Nsor-Atindana et al., 2012) Polyphenols are bioactive compounds 
naturally found in plant sources and have gained a point of interest in recent years 
due to their unique nutritional and functional values including antioxidant, 
antimutagenic, antimicrobial and antitumor effects (Atindana et al., 2012; Tomas-
Barberan et., 2007). 
 
In a recent study reported by Akinmoladun et al., (2016), antioxidant 
containing extracts of cocoa and kola nut tree has shown the protective effect 
against myocardial ischemia-reperfusion injury/IRI using Langerdorff-perfused 
rat hearts. In another study, flavonoids (5-hydroxy derivatives: 5-hydroxy flavone, 
apigenin, chrysin and naringenin) have been stated in improving post-ischemic 
functional recovery and lowering of myocardial tissue injury (Testai et al., 2013). 
On the other hand, in earlier in vitro study of the peripheral blood mononuclear 
human cell, inhibition of IL-1 mRNA expression and T-cells secretion of IL-2 has 
been reported from polyphenol containing Cocoa liquor (Sanbongi et al., 1997). 
However, the previous studies lack biochemical analysis of inflammatory markers 
and signaling proteins activities, and evaluation of myocardial nuclei apoptotic 
levels in rat hearts after IRI.  
 
Additionally, comparison of Cocoa and Recioto red wine/RRW flavonoid 
contents has not been done. Therefore, in this study after comparing flavonoid 
contents in cocoa and RRW, we employed some inflammatory, apoptotic, 
downstream signaling proteins (p-Akt & p-ERK1/2) biomolecular analysis by 
designing immunohistochemistry, TUNEL and additional oxidative stress markers 
approach to investigate the effects of cocoa against IRI in rats which underwent 
LAD induction.  
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1.3. Scientific Classification of Cocoa 
 
The Botanical name of Cocoa is Theobroma Cacao and belongs to family 
Malvaceae (alternatively Sterculiaceae) and is differentiated into three main 
cultivar groups: Criollo, Forastero, and Trinitario, produced in the subtropical 
regions worldwide. Cocoa is one of the world‘s most popular crops, cultivated 
about 8.2 million hectares, having a leading role in the social and economic lives 
of many peoples in poor rural areas (Pohlan and Perez, 2011). The cocoa plant is 
scientifically classified as shown in the table below: 
 
Table: 1. Scientific Classification of Cocoa plant 
 
1 Kingdom                                        Plantae 
2 Subkingdom                                 Viridaeplantae 
3 Infrakingdom                                 Streptophyta 
4 Division                                        Tracheophyta 
5 Subdivision                                    Subspermatophytina 
6 Infradivision                                  Angiospermae 
7 Class                                              Magnoliopsida 
8 Superorder                                     Rosanae 
9 Order                                              Malvales 
10 Family                                            Malvaceae 
11 Genus                                              Theobroma L. 
12 Species                                             Cocoa 
Adopted from Integrated Taxonomic Information System (ITIS, 2011). 
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Figure: 3. Cocoa seeds in the fruit or Cocoa pod and Cocoa tree with pods: 
Fig.1.A shows the cocoa seeds attached on its stem of Theobroma cocoa L. Tree; 
(source Wikipedia) Fig.1.B illustrates the cross-section of cocoa with its pods 
(Adopted from Keith Weller 2004, United States Department of Agriculture). 
 
1.4. Types of Wines in Verona 
 
There are different types of grapes in Verona, such as Garganega, Corvina, 
Molinara and Rondinella grapes, Barbera, Sangiovese, Marzemino, Merlot and 
Cabernet Sauvignon etc. These grapes are involved in making many alcoholic 
beverages and juices (Patricia Guy, 2003; Amarone Tours). To know the amount 
and type of flavonoids that are present in them are unknown. Not surprisingly, 
Verona with the important role it had in Roman age has a very old tradition in 
vine and winemaking. The Valpolicella DOC region is located between Bardolino 
and Soave, just north of Verona. Valpolicella is a red wine made primarily 
from Corvina, Rondinella, and Molinara.  Corvina is considered the superior 
grape and usually, makes up a majority of the blend (Patricia Guy; Amarone 
tours). 
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Figure: 4. Map of Verona regions producing wines (Source Amarone Tours) 
 
Soave is a wine produced from Garganega grapes as a single varietal or 
blend that is one of the most famous of the Italian whites. The Soave DOC is 
located about 10 miles to the east of Verona.  Soave is a dry white wine produced 
from 70% Garganega grapes with Pinot Bianco, Trebbiano di Soave (Verdicchio), 
and Chardonnay making up most of the remaining 30%. The Bardolino region is 
about 30 miles West of Verona, close to Lake Garda. Bardolino is a light red wine 
made primarily from a blend of Corvina, Rondinella, and Molinara grape varieties 
(the same grapes as Valpolicella) (source Amarone Tours). Barbera, Sangiovese, 
Marzemino, Merlot and Cabernet Sauvignon are allowed in small amounts as 
well.  
 
The three wine regions in the north-eastern corner of Italy are often 
referred to as the Tre Venezie, the Three Venices because they were once part of 
the Venetian Empire. Each of these regions produces red and white wines that are 
among the most popular Italian wines outside of Italy (source Amarone Tours). 
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1.5. Recioto Red wine 
 
Recioto has been classified as one of the high-quality red wine of the 
Italian Valpolicella region (Verona, Veneto, Italy) and has been obtained 
Denomination of Controlled and Guaranteed Origin (DOCG) (Dall‘Asta et al., 
2011). Recioto is an intensely flavored, sweet red wine made from dried (passito) 
grapes and most ideal wine (Ferrarini, 1982; Ferrarini & Zironi, 1987; Barbanti et 
al., 2008). Epidemiological studies have indicated that regular and moderate 
consumption of red wine can reduce the risk of cardiovascular-related diseases 
(Lippi et al., 2010; Szmitko and Verma, 2005).  
 
Similarly, resveratrol has been considered as a major component present in 
red wine shows anticarcinogenic activity (Kundu et al., 2004; Shankar et al., 
2007; He et al., 2008) but exists at a low level in red wine as compared to other 
flavonoids such as catechin and epicatechin (Balga et al., 2014). Red wine 
polyphenols show protective effects against angiotensin II-induced hypertension 
and endothelial dysfunction by reducing the NADPH oxidase-dependent 
formation of superoxide anions (Sarr et al., 2006). 
 
1.6. Comparison of flavonoids in Recioto Red wine and Cocoa extract  
 
Presence of flavonoids in different foodstuff and drinks are indicators 
protective effects of the materials on peripheral and central tissues. Therefore, in 
this study, it is important to determine the number of flavonoids in recioto red 
wine and cocoa extract to study further the protective effect against ischemia and 
reperfusion injury. The study evaluating the total antioxidant activity in cocoa, red 
wine, green and black teas has shown highest antioxidant activity in cocoa than 
the other three foodstuffs using the ABTS and DPPH radical scavenging assays 
(Lee et al., 2003).  
 
 
30 
 
1.7. Polyphenols  
 
Phenolic compounds belong to a group of natural substances with variable 
phenolic structures and are found in fruit, vegetables, grains, bark, roots, stems, 
flowers, tea, and wine (Middleton, 1998; Vinson et al. 2001). These natural 
products were known for their beneficial effects on health from centuries before 
flavonoids were isolated as the effective compounds (Stefani et al., 1999). We are 
consuming these abundant micronutrients in our diet with an average of about 1 
gram a day (Scalbert et al., 2005). These phenolic components of fruits and 
vegetables vary not only between different types but also among the cultivars of 
the same type and can even contingent on growing condition and harvesting time. 
Fruits and vegetables are the main sources of phenolic components and many of 
them are well known for their antioxidant and anti-inflammatory activities 
(Ghosh, 2005).   
 
Polyphenols consist of a group of chemical compounds, distinguish by the 
presence of more than one phenolic group; however, the phenolic acids are 
phenols, have only one ring. The polyphenols are included in one of the important 
classes of plant secondary metabolites that contain flavonoids, lignans, stilbenes, 
coumarins and tannins (Harborne, 1993). 
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Figure: 5. Represents Classification and Structure of Polyphenols: 
(Spagnuolo et al., 2016). 
 
The polyphenols belong to wide a range of the heterogeneous group of 
biologically active secondary metabolites in plants, where they help in cell wall 
protection, colourful attractants for birds and insects, defence against various 
environmental stress conditions (intense light, infection, wounding etc) 
(Hakkinen, 2000). The polyphenols are divided into four groups according to their 
phenolic rings and on the structural elements that link these rings: include 
phenolic acids, lignans (known as phytoestrogens; flaxseeds are their oil major 
source), flavonoids (the richest source of human diet), and stilbenes (resveratrol is 
still under observation due to its anti-carcinogenic properties) (Tomas-Barberan, 
2012). 
 
The flavonoids have a basic structure consist of three rings and they are 
subdivided into six families according to their substitution pattern:  anthocyanins, 
flavonols, flavanols, flavanones, flavones and isoflavones which are present in the 
form of catechins in tea, red wine and chocolate, citrus fruits and soya (Shahidi 
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and Naczk, 1995). Although the term ‗polyphenols‘ represents more than 8000 
different structures, only a few of them have been investigated pharmacologically. 
For example, moderate and continuous consumption of red wine has shown 
beneficial effects against onset of cardiovascular diseases due to the presence of 
natural phytoalexin resveratrol, quercetin, delphinidin and (+)-catechin in red 
wine (Kirimlioglu et al., 2008; Kiviniemi et al., 2007; Nasissides et al., 2006).  
 
Three main types of polyphenols are present in the unfermented cocoa 
bean are flavan-3ols or catechins, epicatechins anthocyanins and 
proanthocyanidins and (Misnawi, et al., 2004a; Jalil and Ismail, 2008). The 
phenolic contents in cocoa beans depend upon its genetic makeup, crop season 
and its processing time (Saltini et al., 2013). During the fermentation process, the 
polyphenols combined with cell liquid for oxidation, polymerization, and reaction 
with different proteins (Misnawi et al., 2004b; Wollgast and Anklam, 2000).  
 
Anthocyanins are converted into anthocyanidins and sugar components, 
leucocyanidins are dimerized after hydrolyzation, and (-)- epicatechin are reduced 
to 10-20% due to its soluble in nature (Misnawi et al., 2004a; Wollgast and 
Anklam, 2000).  It has been reported that ripe and unripe cacao pods contain 
exclusively amount of (-)- epicatechin and (+)-catechin but after the fermentation, 
levels these compounds were decreased, but (-)-catechin were found due to heat-
induced epimerization. Additional loss of polyphenols occurs due to some 
nonenzymatic browning reaction, after drying of cacao beans (Hurst et al., 2011). 
A significant loss of polyphenols due to thermolabile flavanols and oxidation of 
catechin and epicatechin with amino acids and proteins to quinones, polymerize 
with other polyphenols in the roasting process (Rusconi and Conti, 2010; Li et al., 
2012).  
 
Antioxidant properties of polyphenols may differ accordingly to the 
arrangement of functional groups around the nuclear structure and their aglycones 
are strong antioxidant than their glycosides (Heim et al., 2002). The polyphenols 
are proton-donor-scavenging radicals (Rice Evans et al., 2002) and act as 
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inhibitors to reduce the oxidative stress, bind carbohydrates, chelate metals and 
proteins (Heim et al., 2002).  Because of these properties, they possess anti-
inflammatory, anticarcinogenic, antibacterial, antihepatotoxic, antiviral, and 
antiallergenic compounds (Zaveri, 2006; Vita, 2005; Arts and Hollman, 2005; 
Rice-Evans et al., 1997).  It has been shown that during the process of chocolate 
making, there is a significant reduction in antioxidant activity and loss of 
polyphenols due to alkalization, high temperatures and presence of oxygen 
(Wollgast and Anklam, 2000).   
 
The polyphenols give a bitter taste to cocoa; however, new approaches 
have been developed for the preservation of cocoa polyphenols contents during its 
processing whilst keeping satisfactory aroma (Schinella et al., 2010). Various 
health benefits inherent in cocoa polyphenols distinguish it and making cocoa as a 
potential functional food. 
 
1.8. Bioavailability of Polyphenols  
 
Bioavailability and absorption of polyphenols depend on their chemical 
structure, food matrix and many other factors like food processing, individual 
variability (genetic makeup of individuals, age, gender and physiological 
disorders), biodiversity of their own intestinal microbiota taxa  and enzymatic 
activity in the colon (D'Archivio et al., 2010; Tomas-Barberan, 2012), are the key 
elements concerning the ability of a person to take almost total amount of  
bioactive derivatives from ingested polyphenols ( Marin et al., 2015).  
 
Natural products like vegetables and fruits, green and black tea, red wine, 
cocoa, coffee, spices and some herbs, as well as nuts and algae,  are the most 
important food sources of polyphenols (Quinones et al., 2013; Sankno et al., 
2005). Some polyphenols are present in all plant products and some are specific to 
food, so that, generally, food consists of complex mixtures of polyphenols 
(D'Archivio et al., 2010). Isoflavones and phenolic acids show the highest 
bioavailability, followed by catechins, flavanones and quercetin glucosides, while 
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anthocyanidins, proanthocyanidins, and galloylated tea catechins are not absorbed 
in all or poorly absorbed (Han et al., 2007).  
 
The polyphenols are conjugated in the form of sulphate, glucuronide and 
methyl groups in the gut mucosa and inner tissues once they are ingested and 
absorbed, where epicatechin and epigallocatechin are transformed into as 
glucuronide and sulphate conjugates. Once flavonoids are ingested sugar moieties 
have been removed from their phenolic backbones and absorbed in the small 
intestine.  Only 55% and 22% of catechin and epicatechin are absorbed in small 
intestine. Proanthocyanidins are in the form of polymers, have high molecular 
weight, and therefore its trimer and dimer are unlikely absorbed in the small 
intestine in their native form, transported into the liver where, they undergo 
methylation, glucuronidation, and sulfation which possess antioxidant capacity 
(Han et al., 2007).   
 
Some unabsorbed polyphenols, they are esterified to sugars, lipids and 
organic acids in the small intestine. There are no enzymes to break these ester 
links in human tissues, then the main site for their metabolism is colon, where 
they meet colonic microbiota then cleaves the conjugating mioties, but most of 
their absorption occurs in small intestine (Marín et al., 2015)  When final product 
as aglycone from small intestine and colon enter blood stream by the portal vein, 
transported into liver, where they may have subjected to conjugated, from where 
they again enter the blood stream until they are excreted in urine (Monagas et al., 
2010; Selma et al.,2009; Stalmach et al., 2010; Nielsen et al.,1998; lee et al., 
2002; Tilgmann et al., 1996; Donovan et al., 2001; Vaidyanathan et al., 2002; 
Crespy et al; 2001; Ouzzine et al., 2003; Marín et al., 2015). Some of the liver 
conjugates back into small intestine as bile product, before being reabsorbed 
again, gut microbial enzymes regenerated these deconjugated compound (Rechner 
et al., 2004; Aura et al., 2008; Cardona et a., 2013). The metabolites that are not 
absorbed are eliminated as feces.   
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All these conjugation reactions are extremely efficient and free aglycones 
are either present in low concentration or absent at all in blood plasma after 
nutritional doses (D‘Archivio et al., 2010; Marín et al., 2015). 
 
 
Figure: 6. The absorption and metabolism of polyphenols: This figure shows 
bioavailability of flavonoids indicating from dietary flavonoids intake, their 
absorptions, and conjugation reactions into the liver and end products through 
tissues, urine, and feces (Marín et al., 2015) 
 
Epicatechin showed a higher absorption in human and its concentration in 
blood plasma detected after 30 mins of the oral dose, reach peak after 2-3 hours 
and back to baseline after 6-8 hours. Generally, polyphenols with low molecular 
weight showed a higher concentration of blood and it higher the chance to reach 
quickly to the target organ (Cooper et al., 2008). The chemical structure might 
also effect the bioavailability of polyphenols, (-) - a form of catechin is almost 10 
times less absorbed than its (+) - catechin form (Cooper et al., 2008).   
 
The bioavailability of polyphenols generally increases with the presence of 
sugars and oils, whereas it decreases in the presence of proteins and lipids 
(Tomas-Barberan, 2012). Milk proteins decrease the bioavailability of epicatechin 
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in chocolate products (Neilson et al., 2010). Serafini et al. (2003) reported 
inhibition of the antioxidant activity of chocolate in vivo due to the presence of 
milk in it. However, this effect has not found in chocolate drinks (Neilson et al., 
2010).  
 
Proteomic techniques demonstrate the study of interactions of cocoa 
polyphenols with milk proteins that have shown the presence of covalent binding 
of free SH-group of the free cysteine residue of protein in protein-polyphenol 
complex formation (Neilson et al., 2010). The study supported by fact that 
alkylation form of peptide is not reacted with flavanols, while lactosylation has 
shown polyphenol binding. Since bioavailability of polyphenols is not 
significantly affected, the only little portion of proteins interacts with polyphenols 
(Gallo et al., 2013).  
 
This study was reported by Roura et al. (2007) and Keogh et al. (2007) 
showed that milk does not have an influence on the absorption and metabolism of 
cocoa powder polyphenols in healthy adults. Sucrose increased the bioavailability 
of polyphenols, but manufacturing process can also affect the extent of sucrose 
impact. It has been observed that bioavailability of polyphenols increases when 
they are consumed after a carbohydrate-rich meal (Schramm et al., 2003). Peters 
et al. (2010) revealed that addition of sucrose in green tea might slow down the 
catechin absorption, partly due to higher viscosity, but it also enhanced catechin 
uptake by the intestine.  
 
1.9. Significance of Cocoa Polyphenols in Cardiovascular Health  
 
Cocoa contains polyphenolic flavonoids components and traditionally 
used by native Indian as a raw unsweetened drinks and dried cocoa powder 
(Grivetti and Howard-Yana, 2009). After reaching to Europe sugar was added and 
other processing steps became popular to minimize bitterness and to give 
European taste and flavor. These alterations resulted in lowering of flavanol 
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content which is a possible polyphenolic with potential antioxidant activity 
(Hristova et al., 2012).  
 
American researchers noted the medicinal importance of cocoa beans. 
When residents of the Island Kuna in South America are observed, are consumed 
a large amount of home-prepared cocoa, full of flavonoids contents and stayed 
hypertension free lives. However, people on Kuna mainland consume 
commercially available cocoa lacking flavonoids. It is found that they develop 
cardiovascular-related diseases and hypertension (Fisher and Hollenberg, 2005). 
On examining the renal hemodynamics, the Kuna Island people have shown a 
high level of NO level, consistent with the positive antioxidant influence of cocoa 
polyphenols on the endothelium (Fisher et al., 2003).  Cacao beans contain 
flavanols, the main flavonoids that are present are catechins and epicatechins 
(Steinberg et al., 2003).  
 
The antioxidant effects of cocoa and chocolate have shown a positive 
correlation with their procyanidin and catechin contents (Wan et al., 2001). These 
are effective antioxidant and enhance cardiovascular system (Desch et al., 2010; 
Corti et al., 2009; Ding et al., 2006). Many studies have grown a point of interest 
for many medical and basic scientists to investigate the effects of cocoa in 
cardiovascular diseases (Corti et al., 2009; Ella et al., 2012). 
 
Cocoa has been considered as a potential medicine from the seventh 
century. It has been described in the European historical documents that chocolate 
is not drunk only for favorable drink or dessert but it is used to treat various types 
of diseases such as cardiac pain and angina (Tomas-Barberan et al., 2007). 
Furthermore, in vivo studies indicate that consumption of chocolate can increase 
the total antioxidant capacity of human blood plasma (Serafini et al., 2003). There 
is a reduction in cardiovascular disease by 37%, diabetes by 31% and stroke by 
29% by the high level of chocolate consumption, shown in recent meta-analysis 
study (Adriana et al., 2011).  
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Various studies have indicated that cocoa has many beneficial effects on 
the risk of stroke, hypertension, insulin resistance, coronary artery disease (CAD), 
cognitive function, dementia and metabolic syndrome (Skelhon et al., 2012; 
Larsson et al., 2012; Hooper et al., 2012; Tokede et al., 2011; Desch et al., 2010; 
Reid et al., 2010; Armitage et al., 2009; Taubert et al., 2007; Henderson et al., 
2007).  
 
Consumption of cocoa on daily basis exerts many useful effects on 
cardiovascular health (Corti et al., 2009). Many researchers have investigated that 
polyphenols rich food or polyphenols have a key role in health protection due to 
their antioxidant activities (Awe et al., 2013; Cooper et al., 2008; Han et al., 
2007). Epidemiologically, it has been found that cocoa intake reduces the 
cardiovascular diseases and all-cause mortality but an inverse relationship with 
the blood pressure (Buijsse et al., 2006). This study has been confirmed in a large 
population (Buijsse et al., 2010). 
 
1.10. Influence of Polyphenols on Health 
 
Polyphenols have shown to scavenge free oxygen radicals and reduce 
oxidative stress by generation and increasing activity of pro-oxidant and 
antioxidant enzymes in the cells (Wang et al., 2006). The well-known property of 
almost every group of flavonoids is their capacity to act as antioxidants. The 
antioxidant ability of flavonoids has been broadly studied in both biological 
tissues and cell-free medium (Woodman et al.,2005;  Magnani et al., 2000; Rice-
Evans et al., 1995; Salah et al., 1995).  
 
Many flavonoids, including quercetin, have shown a reduction in 
ischemia-reperfusion injury by inhibiting with inducible nitric-oxide synthase 
activity (Middleton, 1998; Shoskes, 1998). Silibinin is a flavonoid and act as an 
antioxidant and has been testified to inhibit nitric oxide dose-dependently 
(Sanhueza et al., 1992). It has been observed that quercetin and myricetin present 
in red wine can also enhanced the glutathione/glutathione disulphide 
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(GSH/GSSH) level in rat‘s kidney tissues, showing an antioxidant activity in the 
cell after giving redwine to adult rats (Rodrigo et al., 2002). 
 
Improvement of endothelial dysfunction has been reported in isolated rat 
aorta after treatment of quercetin and isorhamnetin and can reduce oxidative stress 
in the cell (Romero et al., 2009; Sanchez et al., 2007). Because of their best-
described antioxidant ability, several studies have been taken to determine the 
benefical effects of flavonoids for the treatment of many pathological diseases 
such as atherosclerosis, dementia diabetes, cancer and others, these diseases are 
caused due to high level of oxidative stress in the cells (Nijveldt et al., 2001). 
 
.  
Figure: 7. Flavonoids (Fl-OH) scavenging the reactive oxygen species (R°): A 
stable quinone structure will form after Fl-OH gives an H atom to the radical 
(Procházková et al., 2011; Pietta, 2000). 
 
 
Polyphenols are also active vasodilators. Many studies reported that 
flavonoids play an important role in the vasorelaxation and it is mostly facilitated 
through endothelium-independent systems. (Ajay et al., 2003; Chan et al., 2000; 
Herrera et al., 1996). The activity of phosphodiesterases is supressed by the 
flavanone naringenin and provoked vasorelaxation in rat endothelium-denuded 
aorta and caused hyperpolarisation (Qin et al., 2008; Orallo et al., 2005). 
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Various studies have reported that the flavonoids also possess anti-
aggregatory and anti-inflammatory properties (Tomas-Barberan et al., 2007; 
Samman et al., 2001; Serafini et al., 2003). Flavonoids are capable to minimise 
the action of inflammatory signalling pathways, finally preventing the 
unnecessary release of nitric oxide (NO), leukocyte activation and the COX-2 
expression (Zhang et al., 2011; Jakubowski et al 2009; Sio et al., 2006; Xia et al., 
2016) Flavonoids play a key role in the prevention of NF-kB pathway activation 
by reducing the iNOS protein synthesis (Tsai et al.,1999; Yamamoto & Gaynor, 
2001; Testai 2015) 
 
 Flavonoids especially flavones, block key enzymes associated pathways 
including lipoxygenase, cyclooxygenase and phospholipase A2 therefore help in 
decreasing the formation of inflammatory markers like leukotrienes and 
prostaglandins (Harris et al., 2006; Kimata et al., 2000; Lindahl & Tagesson, 
1993; Baumann et al., 1980). Various studies have indicated that flavonoids can 
also inhibit the formation of pro-inflammatory cytokines such as IL-6 , TNF-α and 
IL-1β (Cho et al., 2003b; Gerritsen et al., 1995;). 
 
Resveratrol has shown anti-thrombotic effects and anti-atherosclerotic 
effects in a NO-independent pathway by reducing platelet aggregation, activation, 
and adhesion, thus inhibiting thrombogenesis. Besides, resveratrol also acts as a 
potential inhibitor of both nuclear factor kappa B (NF-k B) dependent gene 
expression and NF-k B activation by preventing inhibitor kappa B (IkB) kinase 
(Holmes-McNary & Baldwin, 2000).   
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Figure: 8. Effects of flavonoids on the mechanism of cardioprotection: The 
chart represents flavonoids` antioxidant, anti-inflammatory and vasorelaxation 
effects on regulatory mitochondrial functions that benefits cardioprotection 
(Testai, 2015). 
 
The antitumor activity of flavonoids is still under discussion and point of 
interest. Antioxidant systems are often inadequate, reactive oxygen species may 
cause carcinogenesis after any damage or injury (Loft& Poulsen 1996; Pryor, 
1997). Reactive oxygen species can cause mutation by damaging of DNA and 
unrepaired or misrepaired division of cells. If these changes occur in critical 
genes, such as in tumor suppressor genes or oncogenes then initiation or 
progression of cells may result (Stefani et al., 1999; Fotsis et al., 1997).  
 
Grapes contain a diversity of antioxidants, including catechin, epicatechin, 
resveratrol, quercetin and proanthocyanidins, resveratrol found mainly in the skin 
of grapes and proanthocyanidins in seeds (Vinson et al., 2001). Some flavonoids 
such as apigenin, fisetin, and luteolin have stated as potential inhibitors of cell 
proliferation (Stefani et al., 1999). 
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1.10.1. Mechanisms of Free Radical Induced Injury Prevention by Flavonoids 
 
 Injury that is caused by free radicals can be prevented through many 
mechanisms such as direct scavenging of reactive oxygen species (ROS) by 
hydrogen atom donation, interaction with other antioxidant enzymes, metal 
chelating activity, reduction of α-tocopheryl radicals, inhibition of oxidases, 
mitigation of oxidative stress caused by nitric oxide, by increasing, plasma urate 
levels and antioxidant properties of other low molecular antioxidants 
(Procházková et al., 2011). 
 
1.10.2. Flavonoids as Pro-Oxidant 
 
Pro-oxidant activities of a flavonoid rely on the number of hydroxyl 
substitutions in its backbone structure. That means the more hydroxyl 
substitutions, the stronger the pro-oxidant activities of the flavonoids (Cao et al., 
1997).  
 
1.10.3. Antioxidant Property 
 
Many researchers have shown that polyphenols possess many biological 
properties and have an important role in health preservation (Awe et al., 2013; 
Cooper et al., 2008; Han et al., 2007). The important influence of flavonoids is the 
scavenging of oxygen-derived free radicals. The antioxidant property of cocoa and 
chocolate is associated with their catechin and procyanidin contents (Wan et al., 
2001).  
 
The catechins and flavones seem to be the most potent flavonoids for 
defending the body against reactive oxygen species. In acute situations of 
oxidative stress, it has been reported that quercetin and epigallocatechin gallate 
were the strong antioxidants amongst other flavonoids (Qiu et al., 2012). They 
have shown a correlation with cell-death survival signaling pathway which may 
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vary with a dose that inhibits or promote apoptosis, cytoprotective effects or 
exhibiting chemo-preventive respectively (Ramos 2007; Mandel et al., 2004).  
 
1.10.4. Vasodilation and Anti-Inflammatory Properties 
 
A consistent and striking peripheral vasodilation have been observed in 
healthy people due to the short-and long-term intake of cocoa and dark chocolate 
(Bayard et al., 2007; Fisher et al., 2006). Polyphenols, especially flavanols in 
cocoa-related products, have been shown a high level of endothelial nitric oxide, 
which contributes in vasodilation and thus may lower blood pressure (Fisher and 
Hollenberg, 2006; Fisher et al., 2003; Karim et al., 2000). 
 
Cocoa and chocolate products contributes high level of flavonoids among 
commonly consumed foods and also was historically used as a medicine to cure of 
inflammation, pain and numerous other diseases (Tomas-Barberan et al., 
2001)Various evidence indicate that they occur in the form of monomeric flava-3-
ol or procyanidins in cocoa, regular intake of cocoa drinks rich in flavanols can 
strengthen the photoprotective properties of skin, lowers the risk of cardiovascular 
diseases, potent antioxidant, anti-inflammatory and anti-allergic properties 
(Schneider et al., 2001; Reddy et al., 2006; Samman et al., 2001 ).   
 
Cocoa increase NO-dependent vasodilatation in patients with 
cardiovascular risk factors, diabetes and as well as in coronary arteries in healthy 
adults (Balzer et al., 2008; Flammer et al., 2007; Grassi et al., 2005a; Heiss et al., 
2003; Fisher et al., 2003). A study of 18-65 years of women has shown high 
resistance against UV-induced erythema and as well as significant increase in 
blood flow in cutaneous and subcutaneous tissue after 12week continually intake 
of 329 mg cocoa drink (Neukam el al., 2007).  
 
This study is associated with other human trails which show high flow-
mediated dilation (FMD) of conduit arteries and enhanced microcirculation after 
consumption of flavanol-rich cocoa (Schroeter et al., 2006; Heiss et al., 2003). 
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Another study conducted on smokers also demonstrated enhanced flow-mediated 
vasodilation after ingestion of cocoa-rich diet (Heiss et al., 2005).   
 
Cocoa flavanols show promising effects in increasing of cerebral blood 
flow to grey matter up to 60% after a single dose of 450mg of cocoa by 2-3 h 
post-consumption (Francis et al., 2006). Researchers from the University Hospital 
of Cologne collected data from five studies related to the influence of cocoa on 
blood pressure consist of 173 participants, that shows the consumption of cocoa 
rich food has a significant decrease in blood pressure (Taubert et al., 2007).  
 
1.10.5. Effects of Cocoa on Nervous System 
 
The nervous system is one of the body systems, comprises of central and 
peripheral nerves. Many studies have shown neuroprotective effects of 
polyphenols containing foods like cocoa and tea against neuronal cell death (Jain, 
2011; Ramiro-Puig E et al., 2011). In vitro oxidative stress study has also shown a 
neuroprotective effect of cocoa extract and (-)-epicatechin by reducing ROS 
production and modulating MAPK activation (Ramiro-Puig E et al., 2011). 
Human Alzheimer`s disease in vitro study demonstrated neuroprotection effect of 
cocoa polyphenolic extract through brain-derived neurotrophic factor (BDNF) 
survival pathway that is related with canonical nerve growth factor (Cimini et al., 
2013).  
 
Clinical and epidemiological data have also flavonoids and polyphenols 
against neurodegenerative disease in animal models (Cimini et al., 2013). The 
cocoa extract flavonoids interaction with protein and lipid kinases signaling 
cascades inhibit neuronal death via neurotoxicants such as oxygen radicals and 
promote neuronal survival and synaptic plasticity. Thus, it has not only 
neuroprotective effects but also impacts on cognitive performance (Nehlig et al., 
2013). 
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1.10.6. Effects of Cocoa on Cancer 
 
Cancer is one of the main causes of death and disability all over the world 
and it is commonly divided into three stages: initiation, promotion, and 
progression within the cells (Pritchard & Grady 2011). The cell cycle is controlled 
by many regulatory proteins. Any alteration occurs in these specific cell cycle 
regulatory protein or any mutation can result due to unrepaired or misrepaired in 
DNA or during cell division because of many external or internal environmental 
factor may lead to cancer many other carcinogenic diseases (Pan et al.,2011) It has 
been indicated by various epidemiological and experimental studies that dietary 
polyphenols such as, diet that is rich with fruits and vegetables play as important 
role as chemopreventive agents, in the reduction of many cancer-related diseases 
in humans (Mahmoud et al.,2000; Ramos, 2008; Surh, 2003). It has been observed 
that some flavonoids like fisetin, apigenin, and luteolin can help in the inhibition 
of cell proliferation (flav.5) Dietary polyphenols showed a chemopreventive 
effects in colorectal cancer ((Pan et al.,2011; Ramos, 2008). 
 
1.10.7. Effect of Cocoa on Cholesterol Levels  
 
Various evidence indicated that oxidation of Low-density 
lipoprotein (LDL) is a very serious factor in the development of atherosclerosis 
(Steinberg et al., 1989). Fatty streaks will appear by the Uptake of oxidized LDL 
by macrophages and smooth muscle cells and it‘s an early stage of atherosclerosis. 
Due to these vascular changes accumulate an excess amount of lipids like 
cholesterol ester can cause a release of many growth factors by smooth muscle 
cells and fibroblasts (Kume et al., 1994; Kume et al., 1992). Chocolate is a major 
source of catechins and epicatechins revealed by a Dutch study, especially in the 
young population (Arts et al., 1999). In previous studies showed that intake of 
cocoa extract from its powder can increase the resistance against the oxidation of 
LDL and helps in the inhibition of atherosclerosis in hypercholesterolemic rabbits 
(Kurosawa et al., 2005). Intake of dairy cocoa powder can enhance the resistance 
of LDL to oxidation, a study carried out on healthy human adults (Osakabe et al., 
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2001 & Baba et al., 2004). Daily consumption of cocoa powder can decrease 
oxidation of LDL and increase the HDL-cholesterol levels in plasma in humans 
(Baba et al., 2007).  
 
1.10.8. Anti-Diabetic Effect of Cocoa  
 
Recent studies are indicating the anti-diabetic effect of the cocoa extract. 
Flavonoids that is found in cocoa has an anti-diabetic effect through different 
mechanisms either by enhancing insulin secretion, improving insulin sensitivity in 
peripheral tissues such as myocardium, exerting a lipid-lowering effect and 
preventing the oxidative and inflammatory damages that are shown in our study 
that can be associated to diabetes (Ramos et al., 2017). 
 
1.10.9. Effects of Cocoa on Blood Pressure   
 
Cocoa plays a role in the vascular system and on cerebral blood flow 
(Nehlig et al., 2013) that regulate blood pressure. In a study of 856 healthy 
subjects, a significant reduction of blood pressure in 2-18 weeks due to flavonol-
rich cocoa products are reported (Ried et al., 2012). According to University 
Hospital Düsseldorf, 2015 report, the blood pressure lowering potential of 
flavonols that increase flow-mediated vasodilation may be able to reduce the age-
related risk of developing cardiovascular diseases (Sansone et al., 2015). 
Contradicting data are also reported by different studies showing flavonoids pro-
oxidant toxic properties (Procházková et al., 2011).  
 
1.11. Cardiovascular Diseases 
              
Cardiovascular disease (CVD) is one of the important source of death 
both in developing and under developing countries. In 2012, The World Health 
Organisation (WHO) predicted that, seventeen and half million people died from 
CVDs, which accounting roughly about thirty one percent of all worldwide 
deaths.  Among these 7.4 million deaths cases were results of ischemic heart 
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disease (IHD), which cause 46% of deaths in men and 38% in females (Wong, 
2014) and it is estimated by WHO its percentage become double between 1985 
and 2015 (Reddy KS & Yusuf, 1998). 
 
Coronary heart disease is due to development of atherosclerosis, which is 
considered by the increase of cholesterols, white blood cells and fatty acids which 
leads to obstruction of vessels due to limited supply of blood to the heart (Bolli et 
al., 1998). Major problems of coronary heart disease contain ischemia heart 
disease (IHD) and heart failure. There are many risk factors for the occurrence of 
cardiovascular diseases. A recent study that is done in the United States has 
shown in a data of body mass index and waist circumference, the flavonoid intake 
is related to reducing cardiovascular disease risk in the adult population (Sebastian 
et al., 2017). 
 
Figure: 9. Leading Causes of death Worldwide: Ischemic heart disease 
represents number one cause of deaths, 2000-2012. Data adopted from World 
Health Organization, 2014. 
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1.12. Oxidative Stress in Heart 
 
Endothelial dysfunction is associated with premature atherothrombotic 
disease and it is a pathophysiological condition, the most important type of 
endothelial dysfunction is increased in oxidative stress and decreased in NO 
bioavailability in the cells (Oemar et al., 1998; Munzel et al., 2010).  Congestive 
heart failure (CHF) is the most common medical condition, representing the last 
stage of many cardiovascular disorders and is related to high mortality and 
morbidity (Swedberg et al., 2005). Much of evidence has assessed that patients 
with CHF typically display endothelial dysfunction and increased oxidative stress 
(Katz et al., 2005).  
 
Furthermore, patients with reduced Flow Mediated Dilatation (FMD) are 
at high risk for cardiovascular disorders and death (Katz et al., 2005); increased in 
platelet activation results in many atherosclerosis-related problems. Most of the 
complications of Heart Failure (HF) are thrombus-related and CHF showed 
improve platelet activation (Gibbs et al., 2001). Congestive heart failure is the last 
stage of many cardiac disorders and at the time it is impossible to reverse many 
cardiovascular alterations. For example,  a decrease of low-density lipoproteins by 
3- hydroxy1-3-methyl-glutaryl (HMG) coenzyme reductase inhibitors, no more 
minimize the incident rates in ischemic cardiomyopathy patients (Tavazzi et al., 
2008; Kjekshus et al., 2007). Therefore, alternative measurements should be taken 
to improve the condition of these high-risk patients. 
 
1.13. Ischemic Heart Disease 
 
Ischemic heart disease is considered as a common cause of death and 
disability worldwide (World Health Organization, 2008).  IHD, which occurs as 
result of limited blood supply to cardiac myocytes due to partial or total blockage 
of coronary arteries, it may occur in any part of the body such as in any organ, 
muscle and tissue (VDF, 2012) from atherosclerosis due to many risk factors such 
as high blood pressure, smoking, high cholesterol, diabetes, advanced age, a 
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family history of cardiovascular disease, obesity and sedentary lifestyle (VDF, 
2012). 
 
In 1960, Jennings and his co-workers were the first researchers those 
proposed the Myocardial reperfusion injury, they detected unreasonable changes 
after ischemia/reperfusion (I/R) in the canine heart Morphologically, these 
changes were cell swelling calcification in the mitochondria and contracture of 
myofibrils in the canine heart (Jennings et al., 1960). 
 
 
 
 
 
 
 
 
 
Figure: 10A. Representing an overview of heart and artery that shows 
coronary artery disease (ischemia heart area) Fig: 10 B shows the cross-section of 
normal coronary artery with a normal blood flow and partially blocked with 
plaque (Blausen, 2014). 
 
The ischemic region suffers very fast and anoxic cell death in minutes of 
ischemia formation. Irreversible procedures cause rapid energy depletion, 
mitochondrial malfunction, ion pump collapse that results from more than calcium 
accumulation, extracellular potassium, cell swelling which are symptoms of 
necrotic cell death.   
 
During ischemia, hypoxanthine forms by cellular ATP degradation. 
Normally, oxidation of hypoxanthine occurs to xanthine through xanthine 
dehydrogenase. Therefore, during ischemia, xanthine dehydrogenase transforms 
into xanthine oxidase. Despite, xanthine dehydrogenase uses nicotinamide 
A 
B 
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adenine dinucleotide as xanthine dehydrogenase but in ischemia, xanthine oxidase 
uses oxygen as its substrate, and hence, during ischemia, is not possible to 
catalyze the conversion of hypoxanthine to xanthine, resulting in a production of 
the excess amount of hypoxanthine in tissues. When oxygen is restored during 
reperfusion, the formation of toxic ROS occurs due to a conversion of 
hypoxanthine by xanthine oxidase. 
 
 
Figure: 11. The figure represents the mechanism of ischemic-reperfusion 
injury and production of reactive oxygen metabolites (ROMS): Adopted from 
(Gonzalez et al., 2015. 
 
It promotes various serious pathophysiological conditions like stroke, 
myocardial infarction, hypovolemic shock, and peripheral vascular insufficiency 
(Collard and Gelman, 2001). In response to ischemia-reperfusion-induced stress, 
cellular processes become rapidly activated. The ischemic region appears 
immediately in the tissue near to a blocked artery which undergoes quick, anoxic 
cell death within minutes of ischemia (Collard and Gelman, 2001). 
 
Ischemic heart disease (IHD) is the major precursor of myocardial 
infarction (MI). Now common therapies have been developed as primary coronary 
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angioplasty and thrombolysis, to reduce infarct size of heart, restore blood supply 
to heart and decrease mortality (Verma et al., 2002&Chan et al., 2011) Various 
studies indicate that, MI as the most lethal symptom of cardiovascular diseases 
and point of critical investigation of many clinicians and basic medical scientist 
(Timmers et al., 2012). Reperfusion of the ischemic myocardium is the possible 
source for prevention of tissue damage in patients with IHD (Karunakaran et al., 
2006). Therefore, reperfusion, itself responsible for several mechanisms including 
leukocyte infiltration,  endothelial dysfunction and accumulation of reactive 
oxygen species (ROS) in cardiomyocytes that leads to apoptosis (Park & 
Lucchesi, 1905; Frangogiannis et al; 2002; Collard &Gelman, 2001) 
 
The ischemic region can be diagnosed by high values of biochemical 
markers of myocardial necrosis, electrocardiographic (ECG) findings, and 
inflammation by images and can be analyzed by pathology. MI may be the 
primary symptom of coronary artery disease (CAD) or it may appear, frequently, 
in patients with the determined cardiac disease.  It has been investigated that 
reperfusion injury causes 50% of  irreversible myocardial infarct size (Yellon & 
Hausenloy, 2007) indicating that possible pharmacological treatments should be 
required at the time of reperfusion to prevent or reduce myocardial ischemia. 
 
1.14. Inflammatory Response during I/R injury 
     
Even though acute inflammation is a pathophysiological healing response 
triggered during myocardial I/R, accumulation of various evidence shows that the 
inflammatory response that is stimulated while ischemia, and critically increased 
during reperfusion, could itself cause apoptosis of tissues leading to myocardial 
disorders (Hansen, 1995).  
 
Various Inflammatory reactions become activated after I/R injury due to 
the release of cytokines and leukocyte infiltration into the endangered myocardial 
region (Entman et al., 1994). Neutrophils, monocytes, and lymphocytes are the 
main immune cells that are mainly involved in this process; therefore, 
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inflammatory cells produce proteolytic enzymes that cause the development of 
injury (D'Amico et al., 2000; Frangogiannis et al., 2007; Hansen, 1997). 
Chemokines are small chemotactic cytokines that elevate the level of leukocyte 
recruitment to inflammatory sites (Charo & Ransohoff, 2006) However, many 
clinical and pre-clinical studies have shown the contribution of various 
inflammatory markers such as CCL5 and IL-6 in acute cardiac injury (Reichel et 
al., 2006; Empana et al., 2010; Fuchs et al., 2003; Manten et al., 1998). 
 
Endothelium dysfunction may also result due the interface of neutrophils 
with the endothelium and this process occurs by the soluble adhesion molecules 
like E-selectin, P-selectin, intracellular adhesion molecules-1, vascular cell 
adhesion molecule-1 and many more (Entman & Smith, 1994). Clinical studies 
also indicated that  production of high level of white blood cells are directly 
related with the increase the number of mortality rate in patients with acute 
mycardical infarction, demonstrating a close link between a poor prognosis post-
myocardial infarction  and systemic inflammation(Grzybowski et al., 2004). 
 
1.15. Signalling Cascades Associated with I/R Injury 
 
Various signalling cascades could activate during myocardial I/R injury 
due to increase of oxidative stress and Ca2+ overload that‘s leads to cell apoptosis 
or survival. Many strategies have been developing to cure myocardial I/R injury to 
regulate the activation or inhibition of pro-survival and pro-injurious signalling 
transduction cascades in the heart tissue to minimise damaging of cardiomyocyte 
during ischemia reperfusion. 
 
1.15.1. PI3K/Akt Pathway 
 
Phosphoinositide-3-kinase–protein kinase B/Akt (PI3K-PKB/Akt) 
pathway became a point of investigation and identified in the early 1980s during 
characterizing the insulin growth receptor signaling pathway (Alessio et al., 2001; 
Hemmings and Restuccia et al., 2012). Many signaling cascades are participating 
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in cardioprotection. PI3K/Akt signaling transduction cascade is well known for 
one of the major signaling pathway that is directly associated with cell growth or 
cell survival. Phosphorylation of Akt can inhibit cardiomyocytes apoptosis at the 
time of I/R injury (Xia et al., 2016) Previous studies also observed the 
cardioprotective effects of this pathway during I/R injury (Karthikeyan et al., 
2007; Ahmed et al., 2017).  
 
Akt is a serine/threonine kinase signaling protein and belongs to a group of 
protein kinases (protein kinase A/protein kinase G/protein kinase C-like) those 
contain Threonine308 and Serine473 phosphorylation sites in the regulatory and 
kinase domain (Vivanco and Sawyers, 2002). Once Akt becomes activated, 
transfer from plasma membrane to cytoplasm and enter the nucleus, where it has 
many substrates to attach. Phosphorylation by Akt works according to the target 
protein, it can be stimulatory or inhibitory, either enhancing or suppressing the 
effect of proteins (Guertin et al. 2006; Hemmings and Restuccia et al., 2012). 
When PK13/Akt is fully activated it mediates various cellular mechanisms such as 
cell growth, proliferation, cell survival, translation, transcription and cell death 
(Vivanco and Sawyers, 2002). Over stimulation or activation of P13K/Akt 
signaling pathway leads to abnormal cell growth or proliferation cause cancer or 
other infectious diseases (Calvo et al., 2009). Akt 1 regulation enhanced 
physiological cardiac hypertrophy (growth of cardiac cells), while another study 
in mice, it showed an opposite signaling pathological hypertrophy (DeBosch et 
al., 2006; Walsh, 2006). 
 
1.15.2. ERK1/2 Signaling Cascade  
 
In cellular biology, ERK signalling pathway is widely studied among other 
signaling pathways. There are two isomers of Erk: Erk 1 and Erk 2, and they are 
almost 83% similar with each other, showed many common effects during 
signalling pathways, normally it is known as Erk 1/2 (Rose et al., 2010). This is 
also known as p42/p44 MAPK pathway and it contains a chain of proteins that 
transfer a signal from receptor to DNA and form proteins that undergo changes in 
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cells. Upon Stimulation, Ras protein becomes activated then it activates c-
Raf/MAPKKK, which then phosphorylates the Erk1/2 (Rose et al., 2010). When 
it becomes activated it phosphorylates many downstream substrates including 
MAPK-activated protein kinase-1, 90 kDa ribosomal S6 kinases (Frodin & 
Gammeltoft, 1999) and also transcription factor Elk-1 (Davis, 1993). They will 
mediate several regulatory molecules that cause cell differentiation, proliferation, 
and cell survival (Frodin & Gammeltoft, 1999) and various human diseases may 
occur due to abnormal regulation of MAPK cascades (Roberts and Der, 2007). 
 
It has been observed in many studies that activation of Erk ½ signaling 
pathway showed very strong cardioprotective effects during I/R injury. It showed 
a great importance in pharmacological studies, many pharmacological drugs have 
been given during I/R injury to activate the Erk ½ pathway to exerts their 
cardioprotective effects, there was a reduction of the myocardial infract size in rat 
hearts due to the phosphorylation of Erk ½ (Ikeda et al., 2006). Erk ½ signaling 
pathway showed a positive effect in reducing myocardial infarct size and 
improving post-ischemic cardiac contractility in rat isolated hearts during to I/R 
(Yao et al., 2010). Various studies shows that activation of Erk1/2 causes 
phosphorylation and inhibition of cell pro-apoptotic (BAD (B-cell lymphoma-2-
associated death promoter), caspase-3 andcaspase-9) and cell survival proteins 
such as Bax (B-cell lymphoma-2-associated X protein) in the cells (Hausenloy & 
Yellon, 2007).  
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Figure: 12. Represents Schematic diagram of Cell survival or Reperfusion 
Injury RISK Pathway: During ischemia/reperfusion, due to stimulation of 
Growth factors e.g TGFβ 1 and G-protein coupled receptor, two cardioprotective 
signalling pathways Erk 1/2 phosphatidylinositol 3′-kinase (PI3K)/protein kinase 
B (Akt) pathways become activated. They are extracellular signal-regulated 
kinases and congregate at the mitochondria, where phosphorylation and 
inactivation of pro-apoptotic proteins Bax (Bcl-2-associated X protein, BAD (Bcl-
2-associated death promoter), Caspases-3 & 9 occurs and that result in cell 
survival (Hausenloy & Yellon, 2004). MEK= mitogen-activated protein kinase 
kinase; TGF= transforming growth factor. 
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1.16. Aims of the Study 
 
1.16.1. General Objective 
 
The aim of this study was to investigate the effects of cocoa extract in 
ischemia-reperfusion-induced myocardial tissues in Sprague-Dawley rats. 
 
1.16.2. Specific Objectives 
 
• To compare the flavonoid amount in both Cocoa extract and Recioto Red 
Wine 
• To determine optimal cocoa extract dose in Sprague-Dawley rats 
• To translate cocoa extract optimal dose from rats to human 
• To measure oxidative stress in myocardial tissue of Cocoa treated rats 
following ischemia and reperfusion 
• To observe histopathological changes in myocardial tissue sections using 
hematoxylin and eosin staining 
• To analyze the sensitivity of inflammatory markers on myocardial tissue in 
Cocoa extract treated rats 
• To demonstrate the apoptotic levels of myocardial nuclei in Cocoa treated 
rats  
• To analyze phosphorylation of ERK1/2 and Akt signaling proteins in 
myocardial tissue of Cocoa treated rats 
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CHAPTER TWO 
 
2.1. MATERIALS AND METHODS 
 
2.2. Design of the study 
 
This study was experimentally designed to investigate cardioprotective 
effects of cocoa on the heart of rats. In this study, it was first designed to compare 
amounts of flavonoids in cocoa and Recioto red wine and then, oral administration 
of cocoa for 15days to determine the optimal dose at which saturation dose begins 
from the sera of the blood. Finally, it was planned to administer optimal dose 
orally for 15 days to study biomolecular analysis after 30min of ischemia and 24 
hrs of reperfusion (Fig. 1.) after observation of heart and blood samples. 
 
 
Figure: 13. Experimental study design: The sketch showed the experimental 
design of the study using a total of 60 Sprague-Dawley rats divided into 30 rats 
for flavonoids amount identification and 30 rats for effects of cocoa extracts on 
the myocardial tissue after induction of 30min ischemia and 24hrs reperfusion. 
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2.3. Chemicals & Materials Used 
 
Cocoavia® and Recioto red wine (four-year-old) were purchased from 
Trademarks Mars Inc, USA and by Masi Agricola, Verona Italy. Reduced 
glutathione (GSH), glutathione reductase, gamma-glutamyl p-nitroanilide, 
glycylglycine, bovine serum albumin (BSA), 1,2-dithio-bis nitro benzoic acid 
(DTNB), 1-chloro-2,4-dinitrobenzene (CDNB), reduced nicotinamide adenine 
dinucleotide phosphate (NADPH), CCl4, flavine adenine dinucleotide (FAD), 
glucose-6-phosphate, 2,6-dichlorophenolindophenol, thiobarbituric acid (TBA), 
picric acid, sodium tungstate, sodium hydroxide, trichloroacetic acid (TCA) were 
purchased from Sigma. Primary antibodies CCL5/RANTES, ICAM1, Nitro-
tyrosine, IL-6, NFkB2, P-Erk, and P-Akt antibody were obtained from BIOSS 
antibodies, Novusbio and cell signaling technology. In Situ Cell Death Detection 
Kit, AP was from Roche. 
 
 
Figure: 14. The figure represents Cocoavia® extract and Recioto red wine 
used for the study. 
  
2.4. Animals  
 
Eighteen healthy  Sprague-Dawley (SD) male rats weighting 300-350g 
were employed and kept in a setup cage system in a 21±2
o
C room. They fed with 
food (ad libitum) and water. They were adapted to the laboratory conditions for a 
week prior to the experiment. First rats were used for dose-response experiment 
and thirty SD male rats used for the biochemical and immunohistochemistry 
analysis after animal treatment and ischemia-reperfusion. All animal experiments 
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were done per ethical guidelines reviewed and approved by University of Verona 
Ethical Committee and the Italian Ministry of Health (341/2016-PR) at 
C.I.R.S.A.L. (Interdepartmental Research Centre for Laboratory Animals) of the 
Biological Institutes, University of Verona, and Verona, Italy.  
 
2.5. Extraction of Recioto Red wine and Cocoavia® 
 
Extraction of total Phenolic compounds from the four-year-old age 
Recioto red wine (provided by MASI AGRICOLA, Verona Italy) was carried out 
by diluted with 100% LC-MS methanol, prior to that filtered the wine through 
Minisart RC4 0.2µm pore filter. In case of cocoa pills-powder (provided by 
Trademarks Mars, Inc) was weighted and diluted into three times of ice-cold 
methanol and vortex. Sonification was carried out for 15 min at 40 kHz in 
ultrasonic bath (Falc Instruments, Bergamo, Italy) at room temperature, 
centrifuged for 10 min at 16,000 g at 4°C and filtered through 0.2 µm pore filters 
following protocol (Dal Santo et al., 2016; Calderón et al., 2009). For the LC-MS 
chromatograph analysis, made serial dilutions with methanol both for wine 
sample (1:2, 1:3, 1:10, 1:20, and 1:25) and cocoa sample (1:2,1:10, 
1:20,1:50,1:100 and 1:200). Before the injection the samples were diluted 1:2 with 
LC-MS water (Fluka) and injected volume was 20µl. 
 
The chromatographic analyses were carried out by using a Beckman 
CoulterGold 127 HPLC system (Beckman Coulter, Fulletron, CA) equipped with 
a C18 guard column (7.5 x 2.1 mm) and an analytical Alltima HP C18 column 
(150 x 2.1 mm, particle size 3 µm) (Alltech Associates Inc, Derfield, IL). Two 
eluents were used: 0.5% (v/v) formic acid, 5% (v/v) acetonitrile in water (buffer 
A), and 100% acetonitrile (buffer B) using gradient program from (-); flow rate 
200 µl min
-1 
 
Each sample was analyzed in two technical and three biological replicates, 
with 20 µl injection volumes and 31 min equilibration between samples. The 
HPLC system was coupled on-line with a Bruker ion trap mass spectrometer 
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Esquire 6000, equipped with either electrospray ionization (ESI). MS data were 
collected using the Bruker Daltonics Esquire 5.2- Esquire Control 5.2 software, 
and processing using the Bruker Daltonics Esquire 5.2-Data Analysis 3.2 software 
(Bruker Daltonics GmbH, Bremen, and Germany). Negative and positive ion 
mass spectra and MS/MS and MS3 spectra were recorded at target mass of 1000 
m/z; range of 50-3000 m/z with the fragmentation amplitude set at 1 V. In 
addition, the parameters were nebulizing gas was N2:50 psi at 350°C and dry gas 
for both of ion sources10 l min
-1
 for ESI; ESI: capillary source were: 4000 V; end 
plate offset-500 V; skimmer: -40 V; cap exit -121 V; Oct 1 DC: -12 V; Oct 2 DC: 
-1.70 V: lens 1: 5 V; lens 2: 60 V. 
 
 
Figure: 15. Represents High-Performance Liquid Chromatography (HPLC) 
Basic Instrumentation: It contains, Mobile phase (solvent), pump, injector, 
HPLC column (stationary phase), Detector and data analysis. (Source: 
Thyrocare.com).  
 
2.6. Identification of Polyphenols 
 
Metabolites were identified by comparing their retention times, m/z values 
and MS fragmentation patterns with those of commercial standards in our in-
house library. UV/vis spectra recorded by HPLC-DAD were also used to support 
the LC-MS identification as described in (Calderón et al., 2009). Fragmentation 
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patterns collected in online databases such as MassBank (www.massbank.jp) or 
reported in the literature were also considered, especially when no authentic 
standard compounds were available. Neutral losses of 132, 146 and 162 Da were 
considered diagnostic of the loss of pentose, deoxyhexose and hexose sugar, 
respectively. 
 
2.7. Quantification of Polyphenols 
 
The quantification of the Cocoavia® and RDW metabolites in the 
methanolic extracts was carried through HPLC-DAD (Beckman Coulter Gold 126 
Solvent Module coupled to a Gold 168 Diode Array Detector), relying on 
calibration curves of authentic standard compounds.  
 
2.8. Animal Treatment in Dose-dependent Manner 
 
Eighteen SD male rats were divided into six groups of three rats each. 
Among them, group 1 served as control fed with normal rat diet, while the 
animals of other groups were administrated orally with 5,10,15,20 and 25mg/kg 
body weight of Cocoavia® extract dissolved in water, five times per week for 15 
days respectively. All animals were kept at a temperature of 22–24°C and fed with 
a regular pellet diet ad libitum. 
 
2.8.1. Blood Collection 
 
One ml blood was collected, 1 hour after oral administration of Cocoa 
extract from each rat, when showed a higher concentration of flavonoids in 
plasma between 30-60 min as described in (Baba et al., 2000) through lateral tail 
vein following (Lee et al.,2005) on the 1
st
 day, 7
th
 day and 15
th 
day of 
administration. Blood was deposited in clean heparinized glass tubes, centrifuged 
(3500 rpm for 15 min) stored at -80°C for the HPLC-ESI-MS analysis.  
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2.8.2. Preparation and HPLC-ESI-MS Analysis of Sera Samples  
 
The following protocol of rat sera preparation for HPLC-ESI-MS analysis 
was optimized from the deproteination method proposed by (Polson et al., 2003) 
by introducing an initial delipidation step. 
 
For each sample, 200 µL of sera were added to an isovolume of 
chloroform and, after vigorous mixing, the samples were centrifuged (16000 rcf, 
15, 4°C). Chloroform phases including the lipid fraction were discarded, whereas 
the upper phases were recovered and added to three volumes of cold ethanol to 
precipitate the protein fraction. After vigorous mixing, the samples were let for 10 
min at room temperature and then centrifuged as above.  
 
Supernatants were passed through Minisart 0.2-µm filters and 20 µL was 
injected in a column for the HPLC-ESI-MS analysis. The latter was performed as 
described in the previous paragraph using the same chromatographic method and 
keeping the MS parameters unvaried. The absence of ion suppression due to 
possible matrix effect in HPLC-ESI-MS analysis was evaluated by spiking 0.01 
µg of (+)-catechin in one sera sample. The presence of characteristic metabolites 
detected in Cocoavia® extracts and of those potentially derived from their 
catabolism in mice was investigated in chromatograms recorded in negative 
ionization.  
 
2.9. Animal Groups and Ischemia-reperfusion Surgery  
 
Ten SD male rats were divided into two groups control and treated five in 
each group.  The selected dose 15mg/kg of cocoa from our previous results was 
given to a treated group (n=5) once in a day for 15 days. Control group remained 
untreated. At the end of the experiment, after 12 hours, 30 min of ischemia was 
given to left anterior descending artery (LAD) of heart and 24hrs of perfusion was 
given to both groups. 
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2.10. Surgical Procedure for Ischemia and Reperfusion  
 
Thirty rats were divided into two groups (control and treated). The 
selected dose 15mg/kg of cocoa extract from the dose-response study was given to 
a treated group (n=15) once a day for 15 days. Control group (n=15) remained 
untreated. Subsequently, both groups underwent 30 minutes of myocardial 
ischemia by ligation of the left anterior descending (LAD) coronary artery 
followed by 24 hours of reperfusion. The surgical procedure was produced as 
previously described (Mohanty etl., 2004). Briefly, the rats were anesthetized with 
an intramuscular injection of ketamine (70 mg/kg) and xylazine (5 mg/kg), and 
after a left thoracotomy, the heart was exteriorized by lateral compression of the 
thorax and connected to the descending artery approximately 2 mm from the 
origin with wired polyvinyl (5-0 Ethicon) between the border of the left atrium 
and pulmonary artery. The heart was replaced in the thorax, the lungs were 
expanded with positive pressure, and the pneumothorax was aspirated. All 
surgical procedure was done with the help of surgeons at department of Surgery, 
University of Verona using the protocol indicated by Kolk et al., (2009) and 
Samsamshariat et al., (2005) 
 
 
Figure: 16. Surgical procedures of ischemia and reperfusion using LAD: A, 
The figure represents the surgical procedure of ischemia-reperfusion injury 
performing ligation of the left anterior descending coronary artery (LAD) 
indicating by the yellow arrow. 
 
 
Site of LAD 
A 
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2.10.1. Tissue Collection 
 
After 24hrs, hearts were excised, separated the ischemic part (left 
ventricle) and divided into two portions: 
 
1. One portion of LV (left ventricle) tissue stored in 4% Formalin for 
immunohistochemistry and tunnel analysis. 
 
2. The second portion of the tissue LV was treated with liquid Nitrogen and 
stored at -80 ºC for measurement of oxidative stress.  
                                                                                                                           
2.11. Tissue Processing, Embedding, and Sectioning 
 
Heart tissues (left ventricle) were quickly washed three times for 1 or 2 
min each with phosphate buffer saline (PBS) (pH 7.35, 0.1M) to remove all the 
blood contents from the tissues after collection, then quickly and sufficiently fixed 
with 4% paraformaldehyde and stored at 4 C for long time or at room temperature 
for 24 hours. 
 
For performing immunohistochemistry and TUNEL assays, washed 
samples three times for 10 min each with phosphate buffer saline (PBS) (pH 7.35, 
0.1M) and then dehydrated with three grades of ethanol concentrations (70%, 
90%, 100%) for one hour, one and half hour and one hour each, respectively. 
Delocalization of samples was done by two changes of xylene (100%) for one 
hour. To remove xylene, samples were infiltrated with two changes of molten 
paraffin wax at 56
o
c for one hour. 
 
After the infiltration process, embedding of myocardial tissues was done 
for better sectioning. In the first step, put a small amount of paraffin into cassettes, 
and then transferred the samples with warm forceps into the mold and set in the 
middle of the cassettes according to your desired orientations, and then filled the 
cassettes with melted molten-paraffin wax; handle with care to prevent over or 
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under filling. At last, embedded tissues were placed on ice, and at 4
o
c for 
overnight to make strong paraffin blocks. These paraffin-embedded tissues were 
used to perform different histological and biochemical analysis. 
 
All the embedded samples were cut into 3 µm thickness sections by Leica 
RM 2255 CSA® US digital microtome. To obtained unwrinkled sections, it is 
better to place blocks on ice before sectioning. Put the sections on cold water bath 
and picked up very carefully with back of brushes and put evenly on the FLEX 
IHC coated microscope slides with white-painted label area (Code: K8020, 
K802021-2, Wo503900201, 75mm, W x 25mm, D x 1mm, H), put them on the 
warm water bath to remove wrinkles of sections. 
 
2.12. Immunohistochemistry  
 
Immunohistochemistry is considered as the best method for the analysis of 
inflammation and localization of target molecules in tissues or cells and also 
playing an important role in the research and diagnostics of many diseases 
(Duraiyan et al., 2012). To investigate the inflammation and status of pro-survival 
signaling kinases in cardiomyocytes the following antibodies obtained from Bioss 
antibodies, Novusbio, Abcam and Cell signaling were used:  
 
 CCL5/RANTES (Cat.No.BS1324R),  
 Nitro-tyrosine (Cat. No. BS 8551),  
 IL-6 (Cat. No. 10E5),  
 NFkB2 (Cat, No, ab16502),  
 P-Erk1/2 (Monoclonal Anti-MAP Kinase Activated / monophosphorylated 
/ Phosphothreonine, #M7802 Ab produced in mouse)  
 P-Akt (Ser473, 193H12, #4058) rabbit-mAb.  
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2.12.1. Immunohistochemistry Staining 
 
To access the inflammation in ischemic part (LV) of heart tissues (n=10) 
were decalcified then embedded in paraffin, section 3(μm), deparaffinized and 
rehydrated with xylene (20 min) and graded ethanol concentration (5 min) and, 
then two changes of distilled water (2mins). For antigen retrieval, a microwave 
was used and then the sections were boiled in 10Mm sodium citrate buffer (Ph 
6.0) for 30 mins, sections were then cooled and rinsed three times in distilled 
water and PBS (5min). To suppress Endogenous peroxidase activity, immersed all 
the tissue sections with 3.0% hydrogen peroxide in methanol for 15 mins. To 
permeabilize the tissues, they were rinsed three times in PBS containing 0.1 
Triton X (PBS-TX) and incubated in 5% of horse serum in PBS-TX for 30 mins. 
All sections were incubated with primary antibodies CCL5/RANTES, ICAM1, 
Nitrotyrosine and IL-6 with dilutions 1:300, 1:100, 1:300, 1:100 respectively in 
antibody diluent for 1hour at room temperature and then left over at 4 C for 
overnight.   
 
The tissue sections were rinsed with PBS-TX after an incubation period of 
primary antibodies and then incubated in Biotinylated anti-rabbit secondary 
antibody (Dako Corp.) with 1:400 dilution for 1hour at room temperature. After 
series of washes with PBS-TX, sections were incubated with Avidin-biotin 
complex (The VECTASTAIN
®
 Elite ABC Kit (Standard), Cat. No. PK-6100 
Vector Laboratories, Inc. Burlingame, CA 94010 USA) on each section of tissue 
for 1hr, followed instruction of manufactures guidelines for complex preparation. 
All the sections were rinsed and placed in diaminobenzidine (DAB) in PBS 
containing 0.75% H2O2 and 3% nickel for 5-10 mins to monitor the intensity of 
desired staining. Wash the sections two times, mounted after dehydration in 
graded ethanol series and cleared in xylene.  The negative control was used to 
confirm and check the absence of the signal or specificity of staining. Image 
acquisition of all histological sections was done under Olympus System BX51 
Universal research microscopy. The images were analyzed by using ImageJ 
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software NIH, Bethesda, MD) to quantify the strength of immune-peroxidase 
staining in heart tissue. 
 
2.13. Hematoxylin and Eosin Staining   
 
For hematoxylin and eosin staining procedure, ischemic part of myocardial 
tissues was collected and processed in 4% paraformaldehyde and ethanol and then 
embedded in paraffin-wax. The tissue containing blocks were sectioned at 
3microns. After removing wax from tissues, they were stained by hematoxylin-
eosin staining and silver nitrate. Eosin and Hematoxylin staining solutions were 
prepared by following the procedure shown in appendix 1. 
 
The hematoxylin was dissolved in ethanol. Thoroughly prepare 
ammonium alum solution in distilled water and boiled. After the addition of 
hematoxylin solution to ammonium alum solution, carefully added the glycerol 
and sodium iodide and then added acetic acid one by one in given amount, mix 
thoroughly. 
 
2.14. TUNEL Assay 
 
TUNEL (Terminal deoxynucleotidyl transferase, 2`-deoxyuridine 5`- 
Triphosphate Nick End Labeling) assay is the key tool for the detection of 
apoptotic nuclei of a cell within tissue samples. Apoptosis is a process of 
programmed cell death and as a part of normal development and highly controlled 
and regulated processes during organism life cell cycle.  The apoptotic study is 
very important because any changes occur in these processes can lead to cancer, 
autoimmune and degenerative diseases and many others. Fragmentation of DNA 
is the whole mark of late apoptosis. For the detection of DNA fragmentation, a 
very specific DNA polymerase (terminal deoxynucleotidyl transferase/TdT) attach 
with non-labeled and fluorescently labeled nucleotide 2`-deoxyuridine 5`- 
triphosphate (adds dUTP) at the fragmented end of DNA. When there is a 
breakdown of double-stranded DNA, a great amount of recruitment of the 
independent template (TdT) nucleotide occurs.    
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Cell undergoes apoptosis if there is a breakdown of DNA and this 
apoptosis can be measured by the amount of TdT active within cell through the 
fluorescein-dUTP from double-stranded breaks.   
 
2.15. Measurement of Oxidative Stress 
 
The TBARS (specifically, malondialdehyde – MDA) levels were 
measured spectrophotometrically at 532 nm in the cell lysates using the 
methodology described by (Ben Mansour et al., 2011). GSH content was 
estimated according to the method of (Beutler et al., 1963). The reaction is based 
on the thiol group of GSH reacts with the –SH reagent (DTNB) to form the 
thionitrobenzoic acid. The reaction mixture contained 0.1 M of phosphate buffer 
(pH 7.4), 10 mM of DTNB and 15 µL of the supernatant. The yellow color 
developed was immediately read at 412 nm on a spectrophotometer. The values 
were expressed as ng GSH/µg protein. The catalytic activity of CAT was 
determined as described by (Aebi et al., 1984). The decomposition of the substrate 
H2O2 was monitored spectrophotometrically at 240 nm. The CAT activity was 
calculated in terms of µmol of H2O2 consumed/min/mg protein. The SOD 
activity assay was based on the SOD ability to inhibit the auto-oxidation of 
epinephrine at alkaline medium (Goya et al., 2016). The assay mixture contained 
50 mM glycine buffer (pH 10.0), cell extract, and 60 mM epinephrine (pH 2.0). 
The SOD activity was indirectly measured by the variation in absorbance of the 
oxidized product of epinephrine, i.e., adrenochrome, at 480 nm. 
 
2.16. Microscopy 
 
All sections were studied and acquired images for immunohistochemistry, 
TUNEL and H&E stained sections under Olympus System BX51 Universal 
research microscopy at 10x, 20x, and 40x magnifications. The photographs were 
taken for immunoreactivity and pathological examination. The images were 
analysed by ImageJ software (NIH, Bethesda, MD), the average mean fluorescent 
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intensities (MFIs) were measured by dividing the intensities by area of each 
image. 
 
2.17. Statistical Analysis 
 
All the results were expressed as mean ± SE. Comparison between control 
and treated groups was statistically evaluated by Students t-test and a P value < 
0.05 was considered as statistically significant.  
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CHAPTER THREE 
 
3.1. RESULTS 
 
3.2. Identification of Phenolic Compounds in Cocoavia® and Recioto red 
wine 
 
The unknown metabolites of Recioto red wine and Cocoavia® samples 
were analyzed by using HPLC-ESI-MS followed ESI-base peaks, MS/MS, and 
MS3 fragmentation at their respective retention time and mass to charge ratio 
(m/z).  
 
3.2.1. Identification of Phenolic Compounds in Recioto red wine 
 
The metabolites of Recioto red wine samples were analyzed by using 
HPLC-ESI-MS followed ESI-base peaks, MS/MS, and MS3 fragmentation at 
their respective retention time and mass to charge ratio (m/z). As it is seen from 
the Figure 15 A (+) positive and fig 15 B. (–) negative ion mass LC-ESI/MS 
chromatogram spectra of Recioto red wine and table no.2.Twenty-three at a 
positive and fourteen at a negative ion mass spectrum, different phenolic 
compounds were detected and identified from commercially available Recioto red 
wine. 
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Figure: 17. Identification of phenolic compounds in Recioto red wine: Fig: 
17A. Shows Twenty-three different phenolic compounds were identified at (+) 
ion mass LC-ESI/MS chromatogram and Fig: 17 B. shows fourteen different 
phenolic compounds at (–) ion mass LC-ESI/MS chromatogram were identified. 
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Table: 2. Identification of Phenolic Compounds and Molecular Ions in 
Recioto Red Wine/RRW:  
 
Identified Phenolic components and Molecular ions were detected by MS analysis 
of RRW samples at positive and negative ion mass spectra are under below. 
 
No.         m/z (+) m/z (-) 
1 Proline Epicatechin 
2 Leucine hexose dehydrated Quercetin 
3 Phenylalanine derivative Hydroxytyrosol glucoside 
4 Tryptophane hexose Gallic acid derivative 
5 Adenylosuccinic acid pentose (Epi)catechin ethyl derivative 
6 2-S-glutathionyl-trans-caffeic acid resveratrol tetramer 
7 Malvidin hexose isotope Benzoyl alcohol hexose pentose 
8 Peonidin hexose pyruvate Caffeic acid derivative 
9 Malvidin hexose   Dihydroquercetin deoxyhexose 
10 Delphinidin hexose pyruvate  Kaempferol hexose hydrated 
11 Malvidin hexose pyruvate Dihydromyricetin desoxyhexose 
12 Procyanidin B1  Malvidin derivative 
13 Delphinidin hexose vinylphenol Caffeoyl tartaric acid, 2M-1 
14 Petunidin hexose vinylphenol Catechin derivative 
15 Malvidin acetylhexose pyruvate Dihydromyricetin deoxyhexose 
16 Peonidin hexose vinylguaiacol (Epi)catechin ethyl derivative 
17 2-S-glutathionyl-trans-caftaric acid Dihydroquercetin deoxyhexose 
18 Malvidin hexose vinylguaiacol Quercetin 
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19 Malvidin dihexose Resveratrol tetramer 
20 Malvidin coumaroylhexose pyruvate  
21 Malvidin hexose vinyl (epi)catechin  
22 Malvidin coumaroyl hexosyl hexose 
hydrated 
 
23 Malvidin   acetylhexose 
vinyl(epi)catechin 
 
 
 
3.2.2. Identification of Phenolic Compounds in Cocoa Extract 
 
HPLC-ESI-MS followed ESI-base peaks, MS/MS, and MS3 fragmentation 
at their respective retention time and mass to charge ratio (m/z) analysis was 
performed to identify phenolic compounds in Cocoavia®. As it is seen from the 
Figure (-) negative ion mass LC-ESI/MS chromatogram spectra of Cocoavia®, 
twenty different phenolic compounds from cocoa extract were identified as shown 
in figure (16, c) and in Table 3. 
 
 
 
Figure: 18. Identification of phenolic compounds: Samples of cocoa extract 
(Cocoavia) were analyzed by using HPLC-ESI-MS followed ESI-base peaks, 
MS/MS, and MS3 fragmentation at their respective retention time and mass to 
charge ratio (m/z). Nineteen different phenolic compounds were identified fig 18 
C. 
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Table: 3. Identification of phenolic compounds in Cocoa extract: Identified 
Phenolic molecules from the Cocoavia® samples were analyzed by 
chromatographic mass spectra in negative ion mode. 
 
No.         (-) m/z No. (-) m/z 
1 Di-hexose, Di-hexose [2M-H] 11 Procyanidin pentamer 
2 N-[3′,4′-dihydroxy-(Z)-cinnamoyl]-L-
aspartic acid 
12 Procyanidin monomer 
3 Catechin hexose 13 Procyanidin aptamer 
4 Catechin 14 Procyanidin hexamer 
5 Procyanidin trimer 15 Procyanidin   
6 Procyanidin tetramer 16 Quercetin hexose 
7 Procyanidin B2 17 Procyanidin derivative 
8 Epicatechin 18 Ellagic acid pentose 
9 Procyanidin trimer,  
Catechin derivative 
19 
&20 
(Epi) catechin ethyl 
trimers 
10 Procyanidin tetramer   
 
 
3.3. Determination of Phenolic Compounds 
 
Figure 17 a & b shows the quantitative analysis of RDW and Cocoa 
extract, through HPLC-DAD array, with the same protocol as used for HPLC-
ESI/MS analysis. Statistical analysis was carried out to calculate the amounts of 
phenolic molecules by recording the area of their respective peaks, wavelengths, 
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obtaining the coefficient equation and value of R² for both standards and samples. 
(+)-Catechin (y=5E+06x - 20037, R²=0.997) and procyanidin A2 
(y=3E+06x+8794, R²=0.9998) were used to quantify flavan-3ols and their 
oligomers (absorbance at 280 nm). Caffeic acid (y=3E+07x+231629, R²=0.9999), 
quercetin (y=7E+06x+79102, R²=0.9993) and Resveratrol (y=3E+07x – 54374, 
R²=0.996) were used to quantify hydroxycinnamic acid derivatives (320 nm), 
flavonols (350 nm) and stilbenes respectively as shown in table 4. 
 
Table: 4. The table represents the coefficient equation and value of R² for 
standards at the respective wave lengths. 
 
 
No. Standard used Equation R² 
1 Catechin y=5E+06x - 20037 0.997 
2 Caffeic acid y=3E+07x - 36306 0.997 
3 Resveratrol y=3E+07x - 54374 0.996 
4 Quercetin y = 1E+07x + 12001 0.997 
5 Gallic acid y=1E+07x +19805 0.999 
. 
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Figure: 19. HPLC- DAD analysis of RDW and Cocoavia®: a=Recioto red 
wine & b=Cocoavia®: (a) representing 1: Gallic acid equivalents, 2: caffeoyl 
tartaric acid and 3: catechin derivatives (b) procyanidin 1: catechin. 
 
In Cocoavia® 250 ± 1 mg of flavan-3ols (procyanidin) were found in 
1300mg of cocoa extract capsule, while in case of RDW, the amounts of identified 
molecules were 15±2.69 mg/100ml Gallic acid equivalents, 3.36±1.39 mg/100ml 
Caffeoyl tartaric acid, and 9.04±2.69mg/100ml of Catechin derivatives. So, in one 
liter of a bottle of Recioto wine contains 150mg, 33.6mg, and 90.4mg of Gallic 
acid equivalents, Caffeoyl tartaric acid, and Catechin derivatives. Online data 
bases and in-house library was followed to check the amount of respectively 
identified molecules in Recioto red wine.  
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3.4. Determination of Flavonoids in Rat Serum 
 
Figure 18 showed the total phenolic contents in rat serum calculated by 
HPLC-MS mass spectrometry, between Cocoa extract treated groups (5mg/kg, 
10mg/kg, 15mg/kg, 20mg/kg, and 25mg/kg) and untreated group. Results were 
indicated as (average mean among different time points I
 st
,7
th
,15
th
 day of blood 
collection of treated and untreated groups) cocoa polyphenols increased in blood 
serum as the dose of Cocoa extract increases and became almost remain constant 
after the 15mg/kg of treatment and this dose was considered as optimal dose for 
this study. This optimal does (15mg/kg/bw) could be translated to average human 
body weight (70kg/kg/bw) as 3,000mg of cocoa extract for 15days. 
 
 
Figure: 20. Determination of Cocoa Extract Dose-response in the Blood Sera: 
Quantification of total polyphenols of cocoa extract in blood serum by HPLC-
Mass Spectrometry: Data was expressed as average mean of different time points 
(1st, 7th, 15th day of blood collection of treated and untreated group) and cocoa 
extract (mg/kg) in incremental dose demonstrating 15 mg/kg to be the optimal 
dose of cocoa extract (six groups, n=30) and each group (n=5). 
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3.5. Histopathological Evaluation of Cocoa Treated Rat Myocardial Tissue 
after Ischemia and Reperfusion Induction 
 
Hematoxylin and Eosin stained myocardial tissue of cocoa treated and 
control rats were evaluated under bright field light microscope. Cocoa extract 
treated rat myocardial tissue observed with fewer lymphocytes compared to 
control after induction of ischemia and reperfusion for both groups Fig.  19. 
 
 
 
Figure: 21. Hematoxylin and Eosin Stained Myocardial Tissue in Cocoa 
Treated and Control Rats: interstitial infiltration of lymphocytes which are 
indicators of inflammation was observed in less in cocoa treated myocardial tissue 
section compared to untreated rat heart tissue (x20). 
 
3.6. Expression of Inflammatory Markers (CCL5/RANATES and IL-6) in 
Cocoa Treated Rat Cardiac Tissues 
 
The extent of inflammation of CCL5/RANATES and IL-6 are expressed 
as brown particles in myocardial tissues after 30min of ischemia and 24hr of 
reperfusion in left ventricle through paraffin-embedded samples by 
immunohistochemistry. Myocardial CCL5/RANATES and IL-6 expression were 
significantly elevated in Cocoavia® treated group as compared to control group as 
in Fig. 20 (A, B, C, and D). The reduction of myocardial CCL5/RANATES 
immunoreactivity was found lower in cocoa extract treated rats related to control, 
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p=0.000135. The same result was also found in IL-6 that showed lower IL-6 
immunoreactivity related to control and p=0.001682. 
 
 
 
Figure: 22. Immunohistochemical Analysis of Inflammatory Markers (CCL5 
/RANTES) on Cocoa Treated Rat Myocardial Tissue Compared to Control: 
The myocardial tissues were stained for CCL5/RANTES (A and B) and IL-6 (C 
and D). The graph illustrates increased immunoreactive CCL5/RANTES (A and 
B) and IL-6 (C and D) inflammatory cells in cocoa treated rat (n=15) myocardial 
tissue compared to control (n=15). Representative images (20x). Data illustrated 
in the graphs were presented as mean ± SE. P value less than 0.05 considered as 
statistically significant. Note: CCLS/RANTES, C-C Chemokine Ligand 
5/Regulated on Activation Normal T Cell Expression and Secreted; IL-1, 
Interleukin1.
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3.7. Expression of Nuclear Factor Kappa B Subunit 2 (NF-kB2) in 
Myocardial Tissue of Cocoa Treated Rats Compared to Control 
 
In our immunoperoxidase analysis, immunoreactivity of Nuclear Factor 
Kappa B Subunit 2 (Nf-kB2) which is expressed in different cell type and 
functions as a central activator of genes involved in inflammation and immune 
function was determined. The immunoreactive Nf-kB2 was significantly 
decreased in a group of 15 cocoa treated rat heart tissue compared to control and 
p=0.01. The reduced in Nf-kB2 in cocoa extract treated rat myocardial tissue 
implies the activation of inflammation and immune function.  This result was 
related to the less observed inflammatory lymphocytes in hematoxylin and eosin 
stained myocardial tissue section in cocoa treated rat that is shown in fig 21.  
 
 
Figure: 23. Immunohistochemical Analysis showing expression of NF-kB2 in 
Myocardial Tissue of Cocoa treated Rats Compared to Control: The 
myocardial tissues were stained with NF-kB2. The graph exemplifies increased 
NF-kB2 immunoreactive cells in cocoa treated rat (n=15) myocardial tissue 
compared to control (n=15). Representative images (x20). Data illustrated in the 
graphs were presented as mean ± SE. P value less than 0.05 considered as 
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statistically significant. Note: NFkB2, Nuclear Factor Kappa Subunit B2; IR, 
Immunoreactivity. 
 
3.8. Evaluation of Nitro-tyrosine Immunoreactivity on Myocardial Tissue in 
Cocoa treated Rat after I/R 
 
In our immunohistochemistry analysis, immunoreactivity of Nitro-tyrosine 
which is an indicator of cell damage was evaluated. The immunoreactivity of 
nitro-tyrosine was significantly reduced in a group of fifteen cocoa treated rat 
heart tissue compared to control and p=0.01. This showed lower cell 
damage/oxidative stress that could be due to the treatment of rats with cocoa 
extracts for 15 days. 
 
Figure: 24. Evaluation of Nitrosative Stress on Myocardial Tissue in Cocoa 
treated Rat:  Relative expression of nitrotyrosine in myocardial tissue of cocoa 
treated (n=15) rats compared to control (n=15). Representative images (x20). Data 
illustrated in the graph were presented as mean ± SE. P value less than 0.05 
considered as statistically significant. IR, Immunoreactivity.  
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3.9. Effects of Cocoa Extract on Oxidative Stress on Myocardial Tissue of 
Rats after I/R injury 
 
Oxidative stress was analyzed by detecting levels of TBARS, GSH, and 
the enzymatic activity of both SOD and CAT. In the cocoa extract treated groups, 
a decrease in the TBARS/ MDA levels was observed. The reduction indicated 
lower cardiac membrane lipid peroxidation compared to the control (Figure 23, a). 
Redox status was significantly elevated after cocoa extract administration as 
indicated by GSH levels (Figure 23, b). The activity of SOD and CAT was 
significantly increased (p < 0.001) in the cocoa treated group as compared to 
control group after induction of I/R (Figure 23, c-d). 
 
Figure: 25. Effects of Cocoa Extract on Oxidative Stress on Myocardial 
Tissue Rats: Lower oxidative stress was recorded in cocoa treated rat (n=15) 
myocardial tissue compared to control (n=15). Lipid peroxidation index (TBARS) 
expressed as malondialdehyde (MDA) concentration (A) measured in nmol/µg. 
Reduced glutathione (GSH) content (B), Catalase (CAT) activity (C), and 
Superoxide dismutase (SOD) activity (D). Data illustrated in the graphs were 
presented as mean ± SE. P value less than 0.05 considered as statistically 
significant. 
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3.10. Effect of Cocoa Extract Phenols on Myocardial Nuclei Apoptosis in 
Rats 
The level of cardiomyocytes nuclei apoptotic was determined by TUNEL 
assay. The TUNEL assay showed a significant decline of apoptosis nuclei in 
Cocoa extract treated group (figure 24B) compared to control after 30min of 
ischemia and 24hr of reperfusion episode, p=0.015481. 
 
 
 
Figure: 26. Analysis of Apoptosis by TUNEL Staining on Cocoa Treated Rats 
of Myocardial Tissue Compared to Control: TUNEL fluorescent staining 
showing TUNEL positive nuclei in cocoa extract treated and control (x20). 
Counter staining was performed using DAPI nuclear staining. Cocoa treated (Fig. 
7 A, n=15) myocardial tissue showed higher number of TUNEL-positive nuclei 
compared to control group (Fig. B, n=15). Yellow arrows indicate apoptotic 
nuclei. Data illustrated in the graph were presented as mean ± SE. P value less 
than 0.05 considered as statistically significant. Scale bar = 100µm. TUNEL, 
Terminal deoxynucleotidyl transferase, 2`-deoxyuridine 5`- Triphosphate Nick-
End Labelling. 
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3.11. Effects of Cocoa on Activities of Phosphorylated Extracellular Signal 
Regulated Kinases ½ and Akt Kinases 
 
The phosphorylated extracellular signal-regulated kinases ½ and Akt are 
regulatory protein kinases that involve in proliferation and cell-survival. In our 
immunoperoxidase analysis, the phosphorylation of Akt was significantly 
elevated in cocoa treated rats of myocardial tissue compared to untreated groups, 
p= 0.001. Similarly, the activity p-ERK1/2 was higher compared to control, p= 
0.01. These might show the modulating activities of these two protein kinases in 
cocoa treated rat heart tissue after ischemia and reperfusion.  
 
 
 
Figure: 27. Immunohistochemical labeling of p-Akt and p-ERK1/2 in Cocoa 
Treated Rat Myocardial Tissue Compared to Control: The graphs showed a 
significant elevation on activation of p-Akt and p-ERK1/2 in myocardial tissue of 
cocoa treated rats (n=15) compared to control (n=15). Data illustrated in the bar 
graph were presented as mean ± SE. P value less than 0.05 considered as 
statistically significant. Note: P-ERK1/2, Phosphorylated Extracellular Signal-
regulated Kinases ½; P-Akt, Phosphorylated Serine-Threonine Protein K, x20. 
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CHAPTER FOUR 
 
4.1. DISCUSSION AND CONCLUSION 
 
4.2. Discussion  
 
Cocoa has the highest flavonol contents of all foodstuffs and its extract 
contains a considerable concentration of proanthocyanidins (Goya et al., 2016). 
They are polymeric flavan-3-ols whose antioxidant property hinges on their 
ability to serve as electron donors to terminate the radical chain reaction 
(Lesschaeve et al., 2005). Flavonoids represent a major subset of phenolics, and 
they are highly effective scavengers of most oxidizing molecules and free radicals 
implicated in several diseases (Luo et al., 2017) including cardiovascular diseases.  
 
In our study, comparison of flavonoids` amount has been done in recioto 
red wine and cocoa extract. Commercially available the recioto red wine and the 
cocoa extract powder have been determined to give rise to forty-one and nineteen 
phenolic compounds, respectively. Even though higher number of flavonoids is 
detected in recioto red wine, the amounts of flavonoids are three times higher than 
recioto red wine. This finding goes in line with the study evaluating the total 
antioxidant activity in cocoa, red wine, green and black teas using ABTS and 
DPPH that has shown the highest antioxidant activity in cocoa than the other three 
foodstuffs (Lee et al., 2003).  
 
In the present study, to the best of our knowledge, various concentrations 
of a commercially available epicatechin and catechin containing cocoa extract are 
determined in a dose-response manner in Sprague-Dawley rats for the first time 
and the 15mg/kg/BW dose has been found stable in the bloodstream for 15days. 
This concentration of cocoa extract dose-response assessment is used to establish 
the 15mg/kg optimal dose in a daily administration regimen in order to have 
maximal plasma concentration of polyphenols for cardioprotective 
characterization of cocoa against acute myocardial I/R.  
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In our observational study of rats treated with cocoa extract at higher doses 
(30 and 35mg/kg/bw) has resulted in higher rate of mortality and coagulation of 
blood. The coagulation and higher rate of mortality effects of cocoa extract at 
higher doses might be due to high blood pressure, higher number of platelets 
and/or dehydration. This result shows that rats when treated with cocoa extract at 
30 and 35mg/kg/bw may have adverse effects as compared to 15mg/kg/bw 
treatment for 15 days which has been indicated in our study with protective effects 
against ischemia and reperfusion injury. The implication of this is, lower doses 
(15mg/kg/bw) of cocoa extract have better cardioprotective effect than higher 
doses (30-35mg/kg/bw) in rats treated for 15days. 
 
In our study, a total of 250 mg of flavan-3-ols (procyanidin) have been 
determined in 1gram of cocoa extract. Among them, nineteen different phenolic 
compounds are identified (Figure 16, c and Table 3). We have been hypothesized 
that these phenolic compounds which are found in cocoa extract might have a role 
in the reduction of inflammatory markers, oxidative stress, myocardial apoptosis, 
and in the greater activation of pro-survival downstream proteins in cocoa extract 
treated rat heart. Many studies have shown the protective effect of myocardial 
ischemia-reperfusion injury (Akinmoladun et al., 2016) and in improving post-
ischemic functional recovery (Testai et al., 2013).  
 
Even though flavonoids have many health-related benefits, their 
bioavailability is a major concern and can be affected by absorption and chemical 
structure (Scalbert et al., 2002). The optimal dose could give clue in the 
evaluation of the bioavailability of flavonoids of cocoa in the bloodstream in rats. 
 
Inflammation is a protective functional response of the body tissues to 
harmful stimuli (Goya et al., 2016). Findings of this study have presented a 
reduction in the expression of CCL5/RANATES which recruit leukocytes into 
inflammatory sites in the cocoa treated rat heart (Figure 20). Moreover, the 
significant reduction of inflammatory markers (IL-6 and NFkB) in cocoa extract 
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rat heart (Figure 20 and Figure 21) which are involved in pro-inflammatory 
signaling pathway have been identified in this study. The lower lymphocytes 
observed in histopathological evaluation of cocoa treated rat heart tissue has also 
supported these lowered inflammatory markers in the presence of cocoa extract.  
 
As indicated by different studies (Goya et al., 2016), body tissue responds 
to unfavorable/harmful stimuli by increasing the number of inflammatory markers 
such as IL-6 and NF-κB2. This implies that the detected reduction of 
inflammatory markers in cocoa treated rat myocardium has an advantage in 
protecting the heart against ischemia and reperfusion injury. On the other hand, in 
earlier in vitro study of the peripheral blood mononuclear human cell, inhibition 
of IL-1 mRNA expression and T-cells secretion of IL-2 has been reported from 
polyphenol containing cocoa liquor (Sanbongi et al., 1997). The reduced 
inflammatory markers in cocoa treated rat heart suggest flavonoids found in cocoa 
as a therapeutic target for anti-inflammatory drugs for the treatment of 
cardiovascular diseases. 
 
This study on levels of TBARS, GSH, and the enzymatic activity of both 
SOD and CAT has also shown a decrease in the TBARS/MDA levels in cocoa 
extract treated rat myocardium that implies lower cardiac membrane lipid 
peroxidation compared to the control (Figure 23, a). The redox status was also 
significantly attenuated after cocoa extract administration as indicated by GSH 
levels (Figure 23, b). Similarly, in another study, the decline in TBARS/MDA 
levels is also used as an indicator of lower cardiac membrane lipid peroxidation 
that hampers the cardioprotective effects (Ahmed et al., 2017). 
 
The present study has also shown the elevated activities of SOD and CAT 
in the cocoa treated rat myocardium after induction of I/R (Figure 23, c-d). 
Recently, a study in extracts of cocoa and kola nut tree in the protective effect 
against myocardial ischemia-reperfusion injury/IRI is reported by Akinmoladun et 
al., (2016). This study goes in line with our finding that shows the reduction of 
oxidative stress in cocoa treated rat heart. Another supporting data has stated that 
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improvement of post-ischemic functional recovery and lowering of myocardial 
tissue injury due to the presence of higher amount of flavonoids (Testai et al., 
2013).  
 
In our study on measurement of nitrotyrosine levels, the nitrotyrosine 
levels which indicates nitrosative stress in myocardial tissue has declined in cocoa 
treated rat heart as shown in the figure. 22. The decrease in nitrotyrosine levels 
which is highly associated with lower glucose (Bo et al., 2005) and correlated 
with oxidative stress after ischemia and reperfusion. The reduction of oxidative 
stress and cardioprotective potential of cocoa which are observed in our study 
could be due to the potent antioxidant and free scavenging activities of flavonoids 
(Procházková et al., 2011) or proton-donor-scavenging radicals‘ property of 
polyphenols are also indicated by Rice Evans et al., (2002). These can occur in 
nitrite donors or boosters in the setting of I/R in the potent vasodilator and anti-
inflammatory agent (Darra et al., 2010; Rungatscher et al., 2015) and act as 
inhibitors to reduce the oxidative stress, bind carbohydrates, chelate metals and 
proteins (Heim et al., 2002).  
 
Although intake of cocoa elevates the blood pressure, many studies are 
strengthened the antioxidant effects of polyphenols containing food with respect 
to health benefits (Awe et al., 2013; Cooper et al., 2008; Han et al., 2007). 
Moreover, two observational studies have shown a reduction of the cardiovascular 
diseases and mortality due to the intake of cocoa (Buijsse et al., 2006; Buijsse et 
al., 2010).  
 
In our TUNEL assay that analyzes myocardial apoptosis in cocoa treated 
rat myocardium; myocardial apoptosis has been reduced in rats treated with cocoa 
extract after induction of ischemia and reperfusion (Figure 24). The higher 
apoptosis augments myocardial apoptosis and heart failure in the contrary the 
lower apoptosis protects the heart (Jose et al., 2016). The lower myocardial 
apoptosis observed in cocoa treated rats in this study demonstrates the limiting 
potential of flavonoids containing cocoa in myocardial apoptosis which could be 
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due to lipotoxicity that changes fuel oxidation and mitochondrial dysfunction 
which lead to low energy for myocyte contraction and higher levels of oxidative 
stress and ROS that directly damage and destruct cellular structures that induce 
myocyte apoptosis (Munzel et al., 2015; Sawyer et al., 2002). The toxicological 
study also indicates the contribution of epicatechin and catechin in cocoa in the 
reduction of apoptosis via inhibition of amyloid-β protein (Heo and Lee, 2005). 
The reduced myocardial apoptosis could be due to the antioxidant content of 
cocoa that might contribute to the protection against ischemia-reperfusion injury. 
 
In our study, immuno-peroxidase analysis of p-Akt and p-ERK1/2 in 
myocardial tissue from rats treated with cocoa extract has shown elevation in the 
activity of p-Akt and p-ERK1/2 (Figure 25). Pro-survival downstream proteins 
(Akt and ERK1/2) are known for their contribution to cell survival after ischemia 
and reperfusion injury. They are also known for their mediating action for 
preconditioning in cardioprotection (Zhang et al., 2014). According to Zhang and 
colleagues (Zhang et al., 2014), activation of contributing to the reduction of 
myocardial infarct size and heart dysfunction after reperfusion in rats.  
 
Myocardial ischemia produces a neurohormonal response, phagocyte 
recruitment, mitochondrial dysfunction, and reactive oxygen species formation 
(Giordano et al., 2005) and from infarct area, over time remote sites are affected 
by oxidative stress, energy metabolism abnormalities, extracellular matrix 
alterations and myocytes apoptosis. Therefore, this study suggests that treating 
rats with flavonoids containing cocoa extract diminish CCL5/RANTES, IL-6, 
NFkB, oxidative stress, and apoptosis in the myocardium and the process can be 
modulated by the activities of p-Akt and p-ERK1/2. It is also known sometimes 
flavonoids act as pro-oxidant. Although pro-oxidant properties could be 
considered toxic, these properties could be associated with activities of Akt and 
ERK1/2 protein kinases by which flavonoids work for cardiac cell physiology 
(Procházková et al., 2011).  
 
  
90 
Cocoa contains procyanidins mainly catechin and epicatechin. It is still a 
point of discussion and/or interest that polyphenols don‘t have their own direct 
protective effects to tissues, it might be due to action of microbiota in colon, 
where undergoes methylation, glucuronidation, and sulfation of polyphenols, and 
that are transformed into their aglycones which possess antioxidant capacity (Han 
et al.,2007). These stable forms of aglycones later enter into bloodstream and 
reach to the target tissues and act as antioxidant, anti-allergic, anti-inflammatory 
effects within the tissues. Cardio protective effects of cocoa might be due to the 
indirect by-product of cocoa called aglycones when they are transformed into their 
methylated, glucuronidated, and sulphated forms in myocardial tissue after 
ischemia and reperfusion. 
 
4.3. Conclusion 
 
In this study, cocoa extract oral administration in rats at the optimal 
15mg/kg/BW is found to reduce oxidative stress, myocytes apoptotic nuclei 
levels, and inflammatory markers. It is also found to elevate activities of the pro-
survival protein kinases (Akt and ERK1/2) after induction of ischemia and 
reperfusion.  
 
Based on the findings of this study, it can be concluded that the 
augmentation of cocoa extract once a day for 15days in rats attenuates myocardial 
I/R injury and limits oxidative and nitrosative stress and inflammation with 
reduction of myocardial apoptosis. The optimal dose of cocoa extract that is found 
in rat model may have also a translational value in human. For example, if 70kg 
average body weight of human takes 3,000mg of cocoa extract for 15days may 
have similar effects such as reduction of oxidative stress, apoptosis, and 
inflammatory markers that may be modulated by activities of Akt and ERK1/2; 
however, further study is required.  
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4.4. Recommendations  
 
The above findings are obtained using optimal dose (15mg/kg/bw) at 
moderated chronic duration (15days) after I/R. However, this study recommends 
studies to be done using short-term treatment of rats with cocoa extract to evaluate 
the effect in oxidative stress, apoptosis, inflammatory markers and different 
signaling proteins levels in I/R-induced myocardial tissue of rats. 
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CHAPTER SIX 
 
6.1. APPENDICES 
 
6.2. Appendix I 
 
6.2.1. Hematoxylin and Eosin Staining Protocol 
 
Following chemicals were used in hematoxylin preparation: 
 
1. Hematoxylin  2g 
2. Ethanol absolute 100ml 
3. Ammonium alum 3g 
4. Distilled water 100ml 
5. Glycerol  100ml 
6. Sodium Iodide 0.24g 
7. Acetic acid  10ml 
 
6.2.2. Eosin 
 
It was prepared by dissolving 1g of Eosin in 100 ml of 70% of ethanol. 
 
6.2.3. Hydration 
 
These slides were deparaffinized in xylene as follows: 
 
1. Xylene 1  2-5 minutes at room temperature  
2. Xylene 2  2-5 minutes at room temperature  
 
Tissues were hydrated in graded solutions of alcohol in descending order. 
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3. 100% Alcohol  2-5 minutes at room temperature 
4. 90% Alcohol  2-5 minutes at room temperature 
5. 70% Alcohol  2-5 minutes at room temperature 
6. 50% Alcohol  2-5 minutes at room temperature 
7. 30% Alcohol  2-5 minutes at room temperature 
8. Hematoxylin  1-2 dips 
9. Wash in tap water      5-10 minutes until the tissues were blue  
 
6.2.4. Dehydration  
 
Now cross sections were dehydrated in ascending order in alcoholic grades for 3-5 
minutes. 
 
1. 30% Alcohol 2-5 minutes at room temperature.        
2. 50% Alcohol 2-5 minutes at room temperature. 
3. 70% Alcohol 2-5 minutes at room temperature. 
4. 90% Alcohol 2-5 minutes at room temperature. 
5. Eosin 1-2 dips.  
6. 90% Alcohol 1 dip. 
7. 100% Alcohol 2-5 minutes at room temperature. 
8. Xylene 5-10 minutes. 
 
6.3. Appendix II 
 
6.3.1. Immunohistochemistry Staining 
 
Two changes of xylene for 10 min each 
Two changes of ethanol (100%)/absolute for 5 min each 
Block peroxidase activity with blocking reagent (ready to use) for 10 min  
Wash with PBS and agitate three times for 5 min each 
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Blocking solution for 1hr (ready to use)  
Incubate with 1
o
Ab overnight  
Incubate with 2
o
Ab for 1hr 
Incubate with ABC kit for 1hr (prepare 30min earlier) 
Develop with DAB for 3 min  
Apply DepeX in middle of slide and cover with coverslip 
 
 
 
                
